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ABSTRACT 
 
3,5-Dibromo-2-aminobenzamide was reacted with 1,3-cyclohexanedione derivatives in the 
presence of iodine as catalyst in toluene under reflux to afford novel 6,8-dibromo-2-[3-(2´-
alkyl-1´,2´,3´,4´-tetrahydro-6´,8´-dibromo-4´-oxoquinazoline-2yl)propyl]quinazolin-
4(3H)-ones in high yields. Suzuki-Miyaura cross-coupling of the latter with arylboronic acids 
in the presence of Pd(PPh3)2Cl2–Xphos catalyst complex and K2CO3 as a base in dioxane-
water mixture (3:1, v/v) afforded the corresponding polyaryl-substituted bis-heterocycles in a 
single step operation. The resultant compounds were characterized using a combination of 
NMR (
1
H and 
13
C) and IR spectroscopic techniques, as well as mass spectrometry. The 
electronic absorption and emission properties of these polyaryl-substituted bis-heterocycles 
comprising 2,3-dihydroquinazolin-4(1H)-one and quinazolin-4(3H)-one moieties linked by a 
flexible carbon chain were measured in dimethylsulfoxide (DMSO) and acetic acid by means 
of UV-Vis and fluorescence spectroscopic techniques. The absorption spectra of the resultant 
polyaryl-substituted bis-heterocycles showed blue-shift in acetic acid and red-shift in DMSO, 
while their emission spectra are blue-shifted in DMSO and red-shifted in acetic acid. The 
4-methoxy groups on aryl-substituents caused red shift on π‒π* transition of the aryl-
substituents. Moreover, it was also observed that as the propyl linkage becomes more 
substituted, the absorption and emission intensities decrease. 
 
Keywords: 2,3-dihydroquinazolin-4(1H)-ones, Quinazolin-4(3H)-ones, 6,8-dibromo-2-[3-(2᾿-
alkyl-1´,2´,3´,4´-tetrahydro-6´,8´-dibromo-4´-oxoquinazoline-
2yl)propyl]quinazolin-4(3H)-ones, Suzuki-Miyaura cross coupling, polyaryl-
substituted bis-heterocycles, photophysical properties 
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CHAPTER 1: INTRODUCTION  
 
Nitrogen-containing heterocyclic compounds comprise the topic of at least half of all organic 
chemistry research worldwide, because of their important biological and medicinal 
applications.
1-4
 Among the pharmaceutically important nitrogen-based organic heterocycles, 
the fused pyrimidines, which are found in a variety of natural products,
5
 exhibit a wide range 
of biological properties. These include antibacterial, antifungal, antiviral and antimalarial 
activities,
6
 central nervous system (CNS) depressants and  stimulants.
7
 Quinazolinones, which 
form the basis of this investigation, are a class of heterocyclic molecules consisting of a benzo 
ring fused to pyrimidine ring with one carbonyl group, [i.e. 2,3-dihydroquinazolin-4(1H)-one 
1; quinazolin-4(3H)-one 2; 3,4-dihydroquinazolin-2(1H)-one 3] or two carbonyl groups [i.e. 
quinazoline-2,4(1H, 3H)-dione 4]  on the pyrimidine framework (Fig. 1).  
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Figure 1: Generalized examples of the quinazolinone framework. 
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Among the above mentioned quinazolinones, the 2,3-dihydroquinazolin-4(1H)-ones and 
quinazolin-4(3H)-ones are the most studied derivatives because of their biological properties 
and potential application in material chemistry. Quinazolinone alkaloid febrifugine 5a (Fig. 
2), for example, was first isolated from a Chinese plant Dichroa febrifuga in 1950 and was 
found to exhibit antimalarial properties.
8
 However, this compound was never used in clinical 
trials because it was found to cause severe gastrointestinal disorders.
9
 This drawback led to a 
search for analogues of febrifugine with increased potency and reduced side effects.
10
 In this 
regard, a halogenated febrifugine derivative, halofuginone 5b (Fig. 2), was synthesized and 
found to exhibit coccidiostat activity.
10
 In addition, methaqualone 6, a quinazolinone 
derivative synthesized in 1951
11
 was found to possess sedative and hypnotic effects.
12
 This 
discovery triggered the research on the isolation, synthesis and biological activity studies of 
quinazolinone derivatives and their analogues. For example, fenquizone 7 (Fig. 3), a 2,3-
dihydro-2-phenylquinazolin-4(1H)-one derivative is used for the treatment of oedema and 
hypertension.
13
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Figure 2: R, R'= H (5a)        6 
R = Cl, R' = Br (5b) 
 
The 2,3-dihydroquinazolin-4(1H)-one scaffold can enable the introduction of a different 
degree of unsaturation in the heterocyclic ring through dehydrogenation and subsequent 
aromatization to afford the corresponding quinazolin-4(3H)-ones and quinazoline derivatives, 
respectively. Quinazolin-4(3H)-one-based compounds have been found to exhibit sedative 
3 
 
properties
12
 and some derivatives possess growth inhibitory activity against leukaemia cells.
14
 
The 6-(4-chlorophenyl)-3-[(1-ethylpiperidin-3-yl)methyl]-2-(2-methoxyphenyl)quinazolin-
4(3H)-one 8 (Fig. 3) previously prepared via Suzuki-Miyaura cross-coupling of the 
corresponding 6-bromoquinazolin-4(3H)-one precursor with 4-chlorophenylboronic acid, on 
the other hand, was found to be ghrelin receptor antagonist.
15
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Figure 3: Examples of biologically active quinazolin-4-ones. 
 
The 2,3-dihydroquinazolin-4(1H)-ones
16 
and quinazolin-4(3H)-ones
17 
have also been found to 
exhibit interesting electronic absorption and emission properties and some derivatives have 
potential application as dyes and/ or components of organic light emitting devices (OLEDs). 
Attachment of π-electron donating groups such as aryl substituents directly or indirectly 
through π-conjugated spacers (eg. alkynyl or vinyl groups) to the electron-deficient 2,3-
dihydroquinazolin-4(1H)-one or quinazolin-4(3H)-one skeletons has been found to increase 
the donor-π-acceptor properties of the resultant carbo-substituted quinazolin-4-one 
derivatives.
16,17,18,19
 For example, 2-tert-butyl-2,3-dihydro-3-phenylquinazolin-4(1H)-one 9 
(Fig. 4) in chloroform was found to absorb in the UV region (λab 344 nm) and to emit at 
visible region (λem 409 nm).
17 
The electronic absorption and emission spectra of 2-(4-
methoxystyryl)-3-phenylquinazolin-4(3H)-one 10 (Fig. 4) acquired in acetonitrile at 25 °C, on 
the other hand, also revealed that this compound absorbs in the ultra-violet region 
4 
 
(λab 348 nm) and emits in the visible region (λem 485 nm).
18 
Likewise,
 
the absorption spectra 
of the analogous 2,6,8-triaryl-4-(2-arylethynyl)quinazoline derivatives 11 (Fig. 4) acquired in 
chloroform or dimethylformamide (DMF) revealed that these compounds absorb in the ultra-
violet region λab 270–295 nm and emit in the visible region λem 450−480 nm and 450−500 nm, 
respectively.
19
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Figure 4: Examples of quinazolin-4-ones and quinazoline derivatives with absorption and 
emission properties. 
 
Some of the 2,3-dihydroquinazolin-4(1H)-one and quinazolin-4(3H)-one derivatives have 
been employed as components of dyes or light emitting materials. For example, the disperse 
dyes such as 3-arylazo-2,3-dihydro-2-thioxoquinazolin-4(1H)-ones 12 (Fig. 5) were prepared 
from coupling of the corresponding 2,3-dihydroquinazolin-4(1H)-one diazonium salts with 
5 
 
α-naphthol, β-naphthol, phenol, resorcinol or 8-hydroxyquinoline.20 These dyes were applied 
on polyester fabric and then tested for their fastness to washing, perspiration, rubbing and 
light.
20
 The dyes 12 showed remarkable degree of brightness after washing and good 
perspiration, rubbing and light fastness properties.
20 
On the other
 
hand, a three layered 
greenish-yellow electroluminescent device comprising of 2-[4´-(N,N-dimethylamino)phenyl]-
2,3-dihydroquinazolin-4(1H)-one 13 (Fig. 5) as an emissive layer sandwiched between a hole 
transporting N,N′-diphenyl-N,N′-bis(3-methylphenyl)-1,1-biphenyl-4,4'-diamine (TPD) and an 
electron transporting layer of tris(8-hydroxyquinolinato)aluminium (Alq3) 
{ITO/TPD/MAPQ/Alq3/Al} has since been developed.
21 
In this study, the authors also 
observed that the addition of hole transporting layer and an electron transporting layer did not 
only enhance the luminance of the material, but also narrowed the light emission.
21
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Figure 5: Examples of quinazolin-4(1H)-one based dyes and light emitting materials. 
 
The quinazolin-4(3H)-one-based azo dyes and/ or light emitting materials have also been 
developed. As an example, 3-(4-aminophenyl)-7-nithro-2-phenylquinazolin-4(3H)-one-based 
azo dyes 14 (Fig. 6) prepared from the coupling of the corresponding quinazolin-4(3H)-one 
6 
 
diazonium salts with naphthalene based acid components (i.e. H-acid, J-acid, Korch acid, 
Tobias acid)
22 
were reported to exhibit purple, red, orange, and yellow shades when applied 
on silk, wool or nylon. On the other hand, a weakly blue-fluorescent substrate, sodium 4-
chloro-2-(6-chloro-3,4-dihydro-4-oxoquinazolin-2-yl)phenyl phosphate 15 (Fig. 6), which is 
used as fluoregenic substrate in the field of enzyme-labelled fluorescence (ELF) was found to 
undergo enzymatic cleavage of the phosphate group to yield an extremely photostable  
yellow-green fluorescent precipitate, EFL alcohol 16 (Fig. 6), with maximum emission at 530 
nm.
23 
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Figure 6: Examples of quinazolin-4(3H)-one based dyes and light emitting materials. 
 
Recently, Lu et al. prepared novel bis-heterocyclic derivatives consisting of the 
2,3-dihydroquinazolin-4(1H)-one and quinazolin-4(3H)-one moieties linked by a propyl 
7 
 
chain.
24 
We envisioned that the attachment of various aryl groups on the bis-heterocycles 
framework could lead to derivatives with interesting absorption and/ or emission properties. 
In our view, the conjugative effects of the aryl groups could enhance donor-π-acceptor 
interaction with the π-electron-acceptors quinazolinone moieties. The primary effect of the 
aryl groups would be to shift the π‒π* transition towards the visible region.25 In order to 
realize this goal, we conducted a literature search on the known methods for the synthesis of 
quinazolinones and their bis-quinazolinone derivatives and these are described below. 
 
1.1 Methods for the synthesis of quinazolin-4-ones  
 
Conventional methods for the synthesis of quinazolin-4-ones commonly involve the 
condensation of anthranilamide derivatives with carbonyl compounds, such as ketones, 
aldehydes and dicarbonyl derivatives. A number of these methods will now be discussed in 
the next section. 
 
1.1.1 Synthesis of 2,3-dihydroquinazolin-4(1H)-one derivatives  
 
Several methods for the synthesis of these compounds have been reported in the literature.
26-35
 
These include condensation reactions of anthranilamides with aldehydes or ketones,
26-29 
multicomponent condensations involving isatoic anhydrides, primary amines or ammonium 
acetate and ketones or aldehydes,
32,33
 and metal-mediated condensation reactions.
34,35
 These 
methods are briefly discussed below. 
 
 
 
8 
 
i) The synthesis of 2,3-dihydroquinazolin-4(1H)-ones via condensation reactions of 
anthranilamides with aldehydes or ketones  
 
The synthesis of 2,3-dihydroquinazolin-4(1H)-ones by condensation reactions involves the 
reaction of anthranilamide derivatives with aldehydes or ketones, with the release of water 
followed by intramolecular nucleophilic attack of the amide nitrogen on the activated imine 
group. For example, a mixture of 2-aminobenzamide 17 and the carbonyl derivative (ketone 
or aldehyde) 18 in the presence of cerium ammonium nitrate (CAN) in water was ground at 
room temperature. The mixture was then heated at 60 °C to afford the corresponding 2,3-
dihydroquinazolin-4(1H)-one derivatives 19
 
(Scheme 1).
26
 The grinding step was found to be 
essential to increase the surface area and to facilitate the reaction to lead to increased yields. 
Ding et al. have also employed the grinding technique for the synthesis of 2,3-
dihydroquinazolin-4(1H)-ones by condensing 2-aminobenzamides with aldehydes, in the 
presence citric acid under solvent-free conditions.
27
 The authors found that the presence of a 
nitro group at the ortho-, meta- or para-position of the benzaldehyde derivative had little or 
no effect on the yields of the desired products. Moreover, the use of an aliphatic aldehyde 
such as butanal, as a substrate afforded the desired product in relatively high yield (88%). On 
the other hand, moderate yield (65%) of the desired product was achieved with a long chain 
decanal as substrate. 
N
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R
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Grinding
CAN
 
           17        18         19: R, R´=H, alkyl, aryl 
Scheme 1: Condensation of 2-aminobenzamide 17 with aldehydes or ketones 18 by a 
grinding technique. 
9 
 
 
Other condensation methods reported for the synthesis of 2,3-dihydoquinazolin-4(1H)-ones, 
which make use of 2-aminobenzamide and aldehydes or ketones as substrates, employ silica 
supported polyphosphoric acid
28
 and boric acid or sodium dihydrogen phosphate
29
 as catalysts 
under solvent-free conditions. Microwave irradiation has also been employed for the 
preparation of the analogous 2,3-dihydropyrido[2.3-d]pyrimidin-4(1H)-ones 22 from 
condensation of 2-amino-nicotinonitrile 20 with ketones or aldehydes 21, in the presence of 
aqueous 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) (Scheme 2).
30
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    20           21          22: R, R'= alkyl, aryl 
Scheme 2: Microwave assisted cyclocondensation of 20 and 21 to afford 22. 
 
In another example, aryl amines 23 were reacted with carbon disulphide 24 in alkaline 
dimethylsulfoxide (DMSO) medium to afford intermediate 25, which was in turn, methylated 
with dimethyl sulphate at 0‒5 °C to afford methyl arylcarbamodithioates 26 (Scheme 3).31 
Compounds 26 were further reacted with anthranilic acid in the presence of potassium 
carbonate as a dehydrating agent in ethanol under reflux to afford 3-aryl-2,3-dihydro-2-
thioxoquinazolin-4(1H)-ones 27. These conventional conditions produced compounds 27 in 
56‒72% yields and the reaction involved prolonged reaction time, 20‒22 h.31 Improved yields 
(71‒88%) of compounds 27 were observed within 10‒12 min. when methyl 
arylcarbamodithioates and anthranilic acid were reacted under microwave conditions at 
140 W. The resultant 3-aryl-2,3-dihydro-2-thioxoquinazolin-4(1H)-ones 27 were screened for 
biological properties and were found to exhibit anticonvulsant activity.
31 
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27  
Compound 
Conventional method Microwave assisted method 
Ar % yield Time (h) % Yield Time (min) 
27a C6H5 56 20 71 10 
27b 4-NO2C6H4 67 20 83 11 
27c 4-Cl-2-NO2C6H3 72 22 88 12 
27d 2-Cl-4-NO2C6H3 63 22 85 12 
27e 3-Cl-4-FC6H3 59 21 80 12 
 
Reagents and conditions: (i)   20 M NaOH (aq), DMSO, 0‒5 °C; (ii) DMSO, 0‒5 °C;  
(iii) Anthranilic acid, K2CO3, CH3CH2OH, reflux (conventional 
method) or 140 W (microwave assisted method)  
Scheme 3: Preparation of compounds 27 by conventional and microwave assisted methods. 
 
Another strategy for the synthesis of novel 2,3-dihydroquinazolin-4(1H)-ones involves the 
condensation of more than two reagents, i.e., isatoic anhydride, primary amines or ammonium 
acetate and aldehydes or ketones in single-pot operation as described below. 
 
 
 
11 
 
ii) The synthesis of 2,3-dihydroquinazolin-4(1H)-ones via a one-pot multicomponent 
condensation reactions 
 
A one-pot multicomponent approach involves the reaction of more than two reactants, which 
combine in a sequential manner to yield products that retain the majority of the atoms in the 
starting materials. For example, the one-pot reaction of the isatoic anhydride 28 with 
ammonium acetate as a source of ammonia or primary amines 29 afforded anthranilamide 
derivatives in situ, then followed by condensation with aldehydes 30 promoted by silica 
supported ferric chloride as a catalyst under solvent-free conditions at 80 °C to afford a series 
of 2,3-dihydroquinazolin-4(1H)-ones 31 in 75–91% (Scheme 4).32 It was envisioned by the 
authors (Majid et al., 2011) that the loss of CO2 from the isatoic anhydride is the driving force 
for the formation of a more reactive intermediate that forms the 
2,3-dihydroquinazolin-4(1H)-one product. It was found that the condensation of either isatoic 
anhydride or 2-aminobenzamide with 2-pyridine carbaldehyde does not occur in the presence 
of silica supported ferric chloride, because pyridine acts as a Lewis base and reacts with the 
Lewis acid catalyst (iron(III) chloride). On the other hand, the condensation of the isatoic 
anhydride with ammonium acetate and aldehydes produced the desired products in shorter 
reaction times than the condensation of 2-aminobenzamides with aldehydes which involves 
prolonged reaction times. Rostamizadeh et al. also condensed isatoic anhydride with 
ammonium acetate and aldehydes in the presence of iodine as a catalyst under solvent-free 
conditions to obtain 2,3-dihydroquinazolin-4(1H)-ones in excellent yields (94‒98%) within 
5‒25 minutes.33 Reduced yields were obtained when amines, such as ethylamine, 
methylamine and aniline, were employed in place of ammonium acetate. 
12 
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          28          29  30        31: R, R´= H, alkyl, aryl  
Reagents and conditions: (i) SiO2-FeCl3, 80 °C. 
Scheme 4: Cyclocondensation of isatoic anhydride 28 with ammonia derivatives 29 and 
aldehydes 30. 
 
Methods for reductive desulfurization of 2-thioxoquinazolin-4(3)-ones, or reductive 
cyclization of 2-nitrobenzamides with aldehydes or ketones, which involve the use of 
transition metals as reducing agents to afford 2,3-dihydroquinazolin-4(1H)-ones have also 
been developed and these are described below. 
 
iii) The synthesis of 2,3-dihydroquinazolin-4(1H)-ones via metal-mediated 
condensation reactions 
 
Khurana and Kukreja previously reported the reductive desulfurization of 2-thioxoquinazolin-
4(3)-ones 32 using nickel boride in dry methanol at room temperature to afford 2,3-
dihydroquinazolin-4(1H)-ones 33 (Scheme 5).
34
 The desulfurization of 
2-thioxoquinazolin-4(1H)-ones is thought to proceed through quinazolin-4(3H)-one 
intermediates, which in turn, are reduced to 2,3-dihydroquinazolin-4(1H)-ones. The 
analogous 2-thioxoquinazolin-4(3H)-ones were also prepared by condensing 2-aminobenzoic 
acids with aryl isothiocynates in the presence of nickel boride as a reducing and dethiating 
agent. The nickel boride used as a catalyst was prepared in situ from the reaction of 
anhydrous nickel chloride and sodium borohydride in dry methanol.
34
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(i)
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R
Ar
N
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R
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32 33: R= H, CH3;  
Ar = C6H4, 4-OMeC6H6, 4-ClC6H4 
Reagents and conditions: (i) NiCl2, NaBH4, dry CH3OH, rt. 
Scheme 5:  Formation of 2,3-dihydroquinazolin-4(1H)-ones 33 from 3-aryl-2-
thioxoquinazolin-4(3H)-ones 32.  
 
In another example, Shi et al. previously synthesized a series of 2,3-dihydroquinazolin-
4(1H)-one derivatives 46 by coupling 2-nitrobenzamides 44 with aldehydes or ketones 45, 
using a low-valent titanium reagent. Compounds 44 were first reduced by low-valent titanium 
reagent in situ to anthranilamides, which in turn reacted with compounds 45. The low-valent 
titanium reagent used in this study was prepared in situ by the reduction of titanium 
tetrachloride (TiCl4) with zinc powder in anhydrous tetrahydrofuran (THF) (Scheme 6).
35
  
N
H
N
R''
R'
O
NO2
O
N
H
R'
O
R''
R R
(i)
 
  44              45             46: R, R', R''= H, alkyl, aryl 
Reagents and conditions: (i)TiCl4, Zn-powder, THF, rt. 
Scheme 6: Reactions of 2-nitrobenzamides 44 with ketones or aldehydes 45. 
 
Of importance is that the 2,3-dihydroquinazolin-4(1H)-one framework can allow the 
introduction of different degrees of unsaturation in the heterocyclic ring via dehydrogenation 
14 
 
or aromatization to afford the corresponding quinazolin-4(3H)-one or quinazoline derivatives. 
Examples of the methods for the dehydrogenation of 2,3-dihydroquinazolin-4(1H)-ones and 
aromatization of the resultant quinazolin-4(3H)-ones are described below. 
 
1.1.2 Methods for the synthesis of quinazolin-4(3H)-ones  
 
Quinazolin-4(3H)-ones can be prepared from their corresponding 2,3-dihydroquinazolin-
4(1H)-ones by dehydrogenation, using oxidizing agents to introduce unsaturation between the 
N(1)‒C(2) bond.36-40 Quinazolin-4(3H)-ones can also be prepared directly, and in a single-pot 
operation from the readily available 2-substituted aniline derivatives and various carbonyl 
compounds through oxidative condensation reactions,
41-45
 Aza-reactions
47
 or transition metal-
catalyzed reactions.
49-52
 Selected examples of these methods are described in detail below.  
 
i) Synthesis of quinazolin-4(3H)-ones via dehydrogenation of the 2,3-
dihydroquinazolin-4(1H)-ones  
 
Oxidizing reagents such as 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ),
36
 sodium 
bisulfite (NaHSO3),
37
 copper(II) chloride (CuCl2),
38
 manganese dioxide (MnO2)
39
 and 
potassium permanganate (KMnO4)
40
 have previously been employed to dehydrogenate 
2,3-dihydroquinazolin-4(1H)-ones 47 to their corresponding quinazolin-4(3H)-one derivatives 
48 (Scheme 7).  
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          47                  48: R= Alkyl, Aryl 
Reagents and conditions: (i) DDQ/EtOH, reflux;
36
 NaHSO3/DMA, 150 °C;
37
 CuCl2/EtOH, 
70 °C;
38
 MnO2/CH2Cl2, rt.;
39
 or KMnO4/acetone, reflux.
40
 
Scheme 7:  Dehydrogenation of 2,3-dihydroquinazolin-4(1H)-one moieties 47 to afford 
quinazolin-4(3H)-ones 48 
 
Although effective, these oxidants are often used in stoichiometric amounts or large excess, 
and most are not easy to decompose and therefore pose an environmental threat. As a 
consequence, direct methods for the synthesis of these compounds from anthranilamide 
derivatives have also been developed and these are described in the following sections. 
 
ii) Synthesis of quinazolin-4(3H)-ones via oxidative condensation reactions  
 
Oxidative condensation reaction of 2-aminobenzamide 17 with aldehydes 49 in the presence 
of iron(III) chloride hexahydrate (FeCl3.6H2O) as an oxidizing agent, previously yielded 
quinazolin-4(3H)-ones 50 (Scheme 8).
41
 The 2,3-dihydroquinazolin-4(1H)-ones formed in 
situ by the condensation of anthranilamides with the aldehydes undergoes dehydration 
promoted by FeCl3.6H2O to afford quinazolin-4(3H)-ones. However, this reaction required 
stoichiometric amount (2 equiv.) of FeCl3.6H2O for completion. 
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                      17        49        50: R= H, alkyl, aryl 
Reagents and conditions: (i) FeCl3.6H2O, H2O reflux. 
Scheme 8: Oxidative condensation of anthranilamide 17 with aldehydes 49. 
 
In another example, anthranilic acid 51 was reacted with aniline derivatives 52 (R = H, 2-Cl, 
2-CH3, 3-NO2, 4-Br, 4-CH3, 4-OCH3, 4-NO2) in the presence of the Vilsmeier reagent 
(DMF/POCl3) under microwave conditions to afford the 3-arylquinazolin-4(3H)-one 
derivatives 53 (Scheme 9).
42
 Of interest was that compounds 53 were found to exhibit 
antibacterial and antifungal activities.
42 
OH
O
NH2
NH2
R N
N
O
R
(i)
 
   51     52     53: R = H, 4-CH3, 4-Cl, 2-Cl, 4-OCH3 
Reagents and conditions: (i) POCl3, DMF, microwave, 600 W 
Scheme 9: Condensation of anthranilic acid 51 with anilines 52 to afford 53. 
 
Dimethylsulfoxide (DMSO) has also been used as a solvent and an oxidizing agent in the 
reaction of isatoic anhydride 28 with ammonium acetate 29 and aldehydes 54, this time 
catalyzed by gallium triflate (Ga(OTf)3), to afford quinazolin-4(3H)-ones 55 in high  yields  
(Scheme 10).
43
 DMSO in this case was found to serve as a mild oxidising agent to oxidise the 
2,3-dihydroquinazolin-4(1H)-ones generated in situ, into the corresponding 
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quinazolin-4(3H)-ones. The use of solvents such as ethanol or nitromethane, on the other 
hand, afforded the 2,3-dihydroquinazolin-4(1H)-ones, exclusively. 
(i)
N
H
O
O
O
NH4OAc
R
O
H
N
NH
O
R
 
                            28                29              54            55 
Compound R %Yield 
55a C6H5 83 
55b 4-ClC6H4 89 
55c 4-BrC6H4 86 
55d 2,4-(CH3O)2C6H3 89 
55e 4-HOC6H4 92 
55f 4-FC6H4 84 
55g 4-NO2C6H4 82 
55h 3-NO2C6H4 82 
55i 4-CH3C6H4 84 
55j 4-CH3OC6H4 82 
 
Reagents and conditions: (i) Ga(OTf)3, DMSO, 85 °C 
Scheme 10: Ga(OTf)3-mediated cyclocondensation of 28 with 29 and 54. 
 
A single-pot oxidative condensation of 28 with benzyl halides 56 and amines 58 in DMSO in 
the presence of K2CO3 previously produced compounds 60 (Scheme 11).
44
 In this reaction, 
benzyl halide was first converted into benzaldehyde 57 under the Kornblum oxidation 
conditions using a DMSO-K2CO3 mixture. The resultant aldehyde then reacted with the 2-
aminobenzamide 59 which was generated in situ from the reaction of the amine 58 with 
isatoic anhydride 28. Furthermore, DMSO was found to oxidise the 2,3-dihydroquinazolin-
4(1H)-ones generated in situ to the corresponding quinazolin-4(3H)-one derivatives. 
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Reagents and conditions: (i) DMSO, (ii) K2CO3, 90 °C. 
Scheme 11: Oxidative condensation of 28 with 56 and amines 58 in DMSO. 
 
In another example, the reaction of isatoic anhydride 28 with 2-aminobenzimidazole 61 in 
dimethylacetamide under microwave irradiation (600 W) was found to afford 2-amino-N-(1H-
benzo[d]imidazol-2-yl)benzamide 62 (Scheme 12).
45
 The latter, which bears three 
nucleophilic sites was reacted with triethyl- orthoformate 63 in the presence of para-
toluenesulfonic acid (p-TsOH) as catalyst and in dimethylacetamide as solvent under 
microwave conditions (600 W) to afford compound 64 in 70‒95% yield. 
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Reagents and conditions: (i) DMAc, MW; (ii) p-TsOH, DMAc, microwave (600 W). 
Scheme 12: Synthesis of 3-benzimidazolylquinazolin-4(3H)-one 64 via microwave-assisted 
reaction. 
 
iii) Synthesis of quinazolin-4(3H)-ones by Aza-Wittig reaction  
 
This widely used method for the synthesis of N-heterocycles proceeds by a way of cascade 
sequence and it is usually carried out under mild conditions.
46
 As an example, intramolecular 
Aza-Wittig reaction of iminophosphoranes 68,
47 
which were obtained from reaction of 
compounds 65 with perfluoro-tagged phosphine 66 (Rf = CH2CH2C8F17), afforded the 
targeted quinazolinone derivatives 68 (Scheme 13). The perfluoro-tagged phosphine was used 
because it allows simple work-up procedures such as liquid-liquid extraction between 
perfluorinated solvents and organic solvents or one can apply a solid-phase extraction 
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protocols by using fluorous reversed phase silica gels. This reaction occurred in toluene as a 
solvent and trifluorotoluene as a co-solvent. 
O
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P Rf
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N
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O
N
P (Ph-Rf)3
O P Rf
3
N
N
O
R1
R2
65 66
68
66: Rf = CH2CH2C8F17
67
Scheme 13: Synthesis of quinazolin-4(3H)-ones 68 via an aza-Wittig reaction 
 
Non-conventional methods which make use of transition metals as reagents or catalysts to 
prepare quinazolin-4(3H)-ones continue to be developed and these examples are described in 
the following section. 
 
iv) Synthesis of quinazolin-4(3H)-ones or quinazolines via transition metal-catalyzed 
reactions  
 
Imino-Diels-Alder reaction, which involves the reaction of imine derivatives with dienes in 
the presence of Lewis acid catalyst to form pyridine derivatives has been extended to the 
synthesis quinazoline derivatives.
48 Chen et al., for example, previously conducted an 
imino-Diels-Alder reaction of aniline 69 and ethyl glyoxylate 70 in the presence of various 
Lewis acids [i.e. ferric(III) chloride (FeCl3), aluminum(III) chloride (AlCl3), copper(II) 
bromide (CuBr2), zinc(II) bromide (ZnBr2)] as catalysts in refluxing toluene to yield the 
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quinazoline derivative 71 (Scheme 14).
49
 The two α-iminoester intermediate obtained from 
the reaction of 69 and 70 is presumed to form the quinazoline derivative directly. In this 
study, CuBr2 was identified as the best catalyst that produced products in moderate to high 
yields (51‒76% yields).49 
NH2
O
O
O
N
N
O O
O
O
(i)
69: R = 4-OMe, 4-CH3, 4-Cl, 4-Br 70
71
R
R
R
 
Reagents and conditions: (i) CuBr2/toluene, reflux 
Scheme 14: Synthesis of 71 by cascade imino-Diels-Alder reaction. 
 
Copper-catalysed Ullmann coupling reaction has showed great progress in recent years. For 
example, Xu et al. performed the Ullmann coupling reaction of 2-halobenzamides 72 with 
(aryl)methanamines 73 using CuBr2 as a catalyst in the presence of  the K2CO3 as a base and 
air as an oxidant in DMSO to form quinazolin-4(3H)-ones 74 (Scheme 15).
50
 
2-Halobenzamides (X = Cl, Br, I) bearing electron withdrawing groups were found to be 
suitable substrates for this reaction. The authors also employed similar reaction conditions to 
condense 2-aminobenzamides with aryl aldehydes to afford quinzolin-4(3H)-one derivatives 
in high yields.
50 
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            72: X= I, Br, Cl                  73                          74: R = H, 4-NO2, 4-CH3, 5-Cl   
Reagents and conditions: (i) CuBr2, K2CO3, DMSO, air 
Scheme 15: Ullmann-type coupling of 2-halobenzamides 72 with (aryl)methanamides 73  
under aerobic conditions. 
 
Palladium-catalyzed cross-coupling reaction to form carbon-carbon and/ or carbon-
heteroatom bond(s) is a widely used strategy in organic synthesis, and this approach has been 
extended to the preparation of quinazolinones. For example, palladium-catalyzed reaction of 
2-aminobenzamide 17 with benzyl alcohols 75 in water, has been shown to afford the 
quinazolin-4(3H)-ones 76 (Scheme 16).
51
 It was reasoned that the palladium catalysts used in 
this reaction first oxidize the benzyl alcohols to benzaldehydes and then promote the 
cyclization and oxidation of 2,3-dihydroquinazolin-4(1H)-ones generated in situ.  The 
reaction did not occur when using DMSO, ethanol, acetic acid, 1,4-dioxane, or toluene as 
solvents. However, the reaction occurred in aqueous 1,4-dioxane to afford the desired 
products in high yields (72‒90%). Palladium(II) acetate or palladium(II) chloride, in the 
presence of a water-soluble phosphine ligand such as triphenylphosphine monosulfonate 
(TPPMS) were found to be the best catalysts for this transformation. Zerovalent palladium 
catalysts such as tris(dibenzylideneacetone)dipalladium(0) (Pd(dba)3) also afforded the 
desired products in high yields when the reaction was carried out at 120 °C.
51
 The authors 
suggested that the formation of a Pd(TPPMS)n complex from Pd(dba)3 and TPPMS occurs at 
120° C.
51
 It was also observed that benzylic halides, esters, carbonates, or phosphates reacted 
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much better than benzylic alcohols in the presence of Pd(0). Similarly, Zhou and Fang used 
pentamethylcyclopentadienyl iridium dichloride dimer (Cp
*
IrCl2)2 to catalyze the reaction of 
primary alcohols with 2-aminobenzamides to afford quinazolin-4(3H)-ones.
52 
Lower 
reactivity towards oxidation to form aldehydes was observed with benzyl alcohols bearing 
electron-withdrawing groups which then condensed with 2-aminobenzamides to the afford 
desired quinazolin-4(3H)-ones. 
O
NH2
NH2
OH
(i)
N
NH
O
C6H4R
R R
      
17           75   76: R = H, 4-Cl, 4-CH3 
Reagents and conditions: (i) Pd(OAc)2, TPPMS, H2O, 120° C, sealed tube. 
Scheme 16: Synthesis of quinazolin-4(3H)-one 15 via a palladium catalysed reaction. 
 
The quinazolin-4(3H)-one moiety has also been found to undergo N(3) or O-alkylation/ 
arylation/acylation reactions to afford the 4-substituted quinazolines or N(3) substituted 
quinazolin-4(3H)-ones.
53-54
 These compounds are of interest as they have potential 
photophysical
18-19
 or biological  properties.
55-57
 4-Substituted quinazolines were found to be 
active against fungal diseases
55
 and exhibited interesting absorption and emission properties.
19
 
The N(3)-substituted quiazolin-4(3H)-ones, on the other hand, were reported to exhibit 
remarkable absorption and emission properties,
18
 and to possess  antimalarial,
56
 anti-
inflammatory and antitumor properties.
57
 Selected methods for the preparation of these 
isomeric compounds are described below. 
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1.2  N(3) or O-alkylation/arylation/acylation of quinazolin-4(3H)-ones  
 
The reaction of 2-methylthioquinazolin-4(3H)-one 77 with methyl haloacetate derivatives 78 
previously afforded the 4-substituted 2-methylthioquinazolines 79 or N(3)-substituted 
2-methylthioquinazolin-4(3H)-ones 80 exclusively or as a mixture of both products 
(Scheme 17).
53
 The regioselectivity of the reaction was driven by the type of solvent, or base 
used. When the reaction of 77 with 78 was carried out in acetonitrile, in the presence of 
sodium methoxide as a base, the mixture of 79 and 80 was obtained in a ratio of 1:6. The use 
of potassium carbonate in place of sodium methoxide yielded both 79 and 80 in equal 
amounts.
53
 The reaction of bromoacetophenone or ethyl bromoacetate in dimethylformamide 
(DMF) using potassium carbonate as base afforded 79, exclusively. In addition, the use of 
toluene in place of DMF produced 80 without any traces of 79. Alkylation of 
6-haloquinazolin-4(3H)-one with ethyl-4-bromobutanoate in dimethylformamide, on the other 
hand, afforded ethyl 4-[6-halo-4-oxoquinazolin-3(4H)-yl]butanoate.
57 
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N
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R
O
77 78M= K, Na
X= Cl, Br
 
                              79    80: R= CH3, C6H5, OC2H5 
Scheme 17: N/O-acylation of 77 with halo acylmethyl derivatives 78. 
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In another example, aromatization of quinazolin-4(3H)-one 81 with a phosphoryl chloride-
phosphorus pentachloride mixture in boiling water afforded the chlorinated quinazoline 82 
(Scheme 18).
54 
The 4-chloroquinazoline moiety represent suitable framework for further 
transformation such as nucleophilic substitution with heteroatom-based nucleophiles. 
Nucleophilic substitution of 82 with primary amines such as 4-methylaniline or 
aminoalcohols promoted by piperidine in ethanol, for example, afforded the 4-aryl/ 
alkylaminoquinazoline derivatives 83 (Scheme18).
54 
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                  83: R= CH2CH2OH, 4-MeC6H4 
Reagents and conditions: (i) PCl5, POCl3, 70 °C, (ii) NH2CH2CH2OH or 4-MeC6H4NH2, 
piperidine, EtOH, 70 °C. 
Scheme 18: Amination of compound 81 to afford 83.  
 
The 4-halogenoquinazolines also represent suitable substrates for the indirect preparation of 
4-alkoxy-substituted quinazoline derivatives via alkoxylation with alkyl- or aryloxides. This 
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strategy excludes the formation of the isomeric N(3)-substituted derivatives observed from the 
direct alkylation of the NH-3-oxo derivatives. 4-Chloroquinazoline 84, for example, was 
reacted with sodium methoxide 85 in methanol to afford 4-methoxyquinazoline 86 (Scheme 
19).
58 
N
N
Cl
N
N
OCH3
NaOCH3
CH3OH
 
                                        84         85                                 86 
Scheme 19: Alkoxylation of 84 with sodium methoxide to afford 86. 
 
The increased reactivity of the 4-chloroquinazoline moiety due to α-nitrogen effect has also 
been found to facilitate metal-catalyzed cross-coupling reactions to form the 4-carbo–
substituted quinazoline derivatives with ease. Examples of metal-catalyzed cross-coupling 
reactions of halogenated quinazolinone and quinazoline derivatives are discussed in detail in 
the following section. 
 
1.3 Halogenated quinazolinone or quinazoline derivatives as substrates for metal 
catalysed cross-coupling reactions to afford polysubstituted derivatives  
 
The use of halogenated quinazolinone or quinazoline derivatives in metal-catalyzed cross-
coupling reactions allows for the formation of carbon-carbon bond(s) by the displacement of 
halogen atoms and the reactions employ either nickel- or palladium-based catalysts. Examples 
of the mostly widely employed cross-coupling reactions include the following: Kumada 
cross-coupling,
62
 Suzuki cross-coupling,
67
 Negishi cross-coupling,
73 
Sonogashira cross-
coupling,
79
 Heck cross-coupling
83
 and Stille cross-coupling.
87
 These reactions require 
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palladium(0) as catalyst and the Sonogashira cross-coupling reactions also makes use of Cu(I) 
salts as co-catalyst. These cross-coupling reactions generally involve a catalytic cycle which 
proceeds in three steps, namely, (i) oxidative addition; (ii) transmetalation and (iii) reductive 
elimination. The oxidative addition  step involves an in situ reduction of the 18-electron 
palladium pre-catalyst to an active Pd(0) species which is classically thought to be the 14-
electron Pd(0)L2 catalyst (A).
59 
This active Pd(0)L2 catalyst then undergoes oxidative addition 
to a carbon electrophile R
1
X (R
1
 = aryl, hetaryl or vinyl; X = I, Br, Cl or OTf) to afford a 
trans R
1
Pd(II)L2X complex (B).
59-60 
The second step involves transmetalation with either 
copper acetylide (Sonogashira), organostannane (Stille), or organoborane (Suzuki-Miyaura) to 
form intermediate C in which both organic ligands are trans oriented. Trans-cis isomerization 
of complex C affords complex D, which then undergoes a reductive-elimination to afford the 
cross-coupled product with the regeneration of the Pd(0) catalyst (Fig. 7). 
Pd(0)L2
Oxidative 
addition
Transmetallation
Reductive 
elimination
R1X
Nu-
Pd(0) complex or
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L
X
X-
Pd(II)R1
L
L
NuPd(II)R
1
R1
L
LPd(II)Nu
Trans
Trans-cis 
isomerization
R1 Nu
Cis
B
C
D
A
 
Figure 7: General mechanism for Pd(0)-catalyzed cross-coupling reactions. 
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The known reactivity of organohalides, Csp
2–I > Br >> Cl, permits the selective coupling of 
iodides or bromides in the presence of chlorides.
61
 However, this trend does not apply for the 
halogenated 4-chloroquinazolines because the C(4)–Cl bond is highly activated towards 
oxidative-addition due to α-nitrogen effect. Some of the above-mentioned classical cross-
coupling reactions have been employed in the transformation of halogenated quinazolinone 
and/ or quinazoline derivatives.
19,65,66,69,70,72,76,78,80,81,84-86,89  
 
1.3.1 Application of Kumada cross-coupling reactions for the synthesis of 
polysubstituted quinazolinones and/ or quinazolines  
 
Kumada cross-coupling reactions involve the reaction of organomagnesium compounds with 
carbon electrophiles such as aryl halide or heteroaryl halides (Scheme 20).
62
 The reaction 
makes use of nickel-based catalysts such as dichloro(1,3-
bis(diphenylphosphino)propane)nickel [NiCl2(dppp)], or in some cases a palladium-based 
catalysts. Diethyl ether is normally used as a solvent
63
 and the reaction proceeds readily even 
at low temperature. The drawback of this reaction is that it uses Grignard reagents which are 
highly nucleophilic and can affect other functional groups such as aldehydes, ketones, esters, 
and nitro groups.
64 
R1 MgBrX
Pd, or Ni
Catalyst
X R2 MgBr R1 R2
 
Scheme 20: General scheme for Kumada cross-coupling reactions. 
 
Kumada cross-coupling reaction has been employed extensively on 4-halogenated 
quinazolines. For example, the cross-coupling of 4-chloro-2-phenylquinazoline 87 with alkyl- 
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or aryl-Grignard reagents 88, catalysed by manganese chloride in tetrahydrofuran (THF), 
afforded compounds 89 (Scheme 21).
65
  
N
N
Cl
Ph
R MgCl
N
N
R
Ph
(i)
 
          87              88   89: R = Phenyl, i-propyl 
Reagents and conditions: (i) MnCl2 (5 mol %), THF, 0 °C 
Scheme 21: Kumada cross-coupling reaction of 87 with 88 to afford 89. 
 
On the other hand, 2,4-dichloroquinazolines 90 were subjected to Kumada cross-coupling 
reactions with tert-butylmagnessium chloride (t-BuMgCl) in the presence of copper(I) iodide 
(CuI) and in tetrahydrofuran (THF) at 0 °C to afford the 4-tert-butyl-2-chloroquinazolines 91a 
and 91b in 92 and 63% yields, respectively (Scheme 22).
66 
N
N
Cl
Cl
R
R N
N
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Cl
R
R
(i)
  
   90      91: R = H (a); R = OMe (b) 
Reagents and conditions: (i) t-BuMgCl, CuI, THF, 0 °C. 
Scheme 22: Kumada cross-coupling of 90 with t-BuMgCl. 
 
In comparison to the use of palladium or nickel salts, copper(I) iodide and manganese 
chloride offer advantages, such as the mild reaction conditions, the operational simplicity and 
practicability, as well as the low cost. However, the drawback of the Kumada reaction on 
quinazolinones is that it uses strongly basic Grignard reagents which are highly nucleophilic 
and can attack the amide group. 
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1.3.2 Application of Suzuki cross-coupling reactions for the synthesis of 
polysubstituted quinazolinones and/ or quinazolines  
 
The Suzuki-Miyaura cross-coupling procedure involves reaction of organoboronic acids 
compounds and carbon electrophiles such as aryl-/vinylhalides or heteroaryl halides (Scheme 
24).
67
 The availability of organoboron compounds and their high functional group tolerance 
make the Suzuki cross-coupling reaction particularly attractive for the synthesis of polyaryl or 
polyvinyl derivatives. The reaction requires the presence of an inorganic base [e.g. sodium 
hydroxide (NaOH), sodium ethoxide (NaOEt), or potassium hydroxide (KOH)] to activate the 
weakly nucleophilic boranes in the transmetalation step. This cross-coupling reaction 
generally requires high temperatures (80‒110 °C) and water can also be used as solvent or 
co-solvent.
68 
R2
Pd(0), base
Solvent, heat
R1 B(OH)2 X R1 R2
 
Scheme 24: General scheme for palladium-catalysed Suzuki-Miyaura cross-coupling 
reactions. 
 
Suzuki cross-coupling reaction has been employed extensively on halogenated quinazolinones 
and quinazolines to afford novel arylated derivatives. For example, the Suzuki-Miyaura cross-
coupling of 6-bromo-2-cyclopropyl-3-[(pyridin-3-yl)methyl]quinazolin-4(3H)-one 92 with 
phenylboronic acid has been shown to afford 2-cyclopropyl-6-phenyl-3-[(pyridin-3-
yl)methyl]quinazolin-4(3H)-one 93 (Scheme 25).
69
 In this work, several palladium catalysts 
were used as Pd(0) sources in the presence of K2CO3 as base in tetrahydropyran (THP) as a 
solvent. Among the tested palladium catalysts, 1,1'-bis(dicyclohexylylphosphino)ferrocene-
31 
 
palladium(II) dichloride [PdCl2(dcpf)] and 1,1'-bis (di-tert-butylphosphino)ferrocene 
palladium dichloride [PdCl2(dtbpf)] were found to be better catalysts that produced the 
desired product 93 in 84% and 95% yield, respectively. Of interest, compound 93 was found 
to have inhibitory activity against α- glucosidase.69 On the other hand, the 6-aryl-substituted 
quinazolin-4(3H)-ones were found to be ghrelin receptor antagonists.
14
 
N
N
O
N
Br
N
N
O
N
Ph
(i)
 
    92                93 
Reagents and conditions: (i) phenylboronic acid, PdCl2(dcpf) (5%) or PdCl2(dtbpf) (10%), 
K3PO4, THP, rt. 
Scheme 25: Suzuki-Miyaura cross-coupling reaction of 92 with Ph-B(OH)2. 
 
In another example, the 2-aryl-6,8-dibromo-2,3-dihydroquinazolin-4(1H)-ones 94 were found 
to undergo cross-coupling with excess arylboronic acids in the presence of 
bis(triphenylphosphine)palladium(II) dichloride [PdCl2(PPh3)2] as catalyst, 
2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl (X-phos) as a ligand, potassium 
carbonate (K2CO3) as a base in  DMF-water mixture at 120 °C to afford the corresponding 
2,6,8-triaryl-2,3-dihydroquinazolin-4(1H)-ones 95 (77–91%) without selectivity 
(Scheme 26).
70  
Lack of selectivity was also observed on Suzuki-Miyaura cross-coupling of 
analogous 4-alkynylated-6,8-dibromo-quinazolines.
19
 This non-selectivity is presumed to be 
due to comparable bond strength of C‒Br bonds. Computational studies have confirmed that 
bond dissociation energies at B3LYP and G3B3 levels of all the positions on the fused benzo 
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ring of various heterocycles bearing identical halogen atoms have comparable C‒X (X = Br, 
Cl) bond dissociation energies.
71 
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                 94                 95: R = 4-H, 4-F, 4-Cl, 4-OMe;  
               Ar = C6H5, 4-FC6H4 
Reagents and conditions: (i) ArB(OH)2 (2.2 equiv.), PdCl2(PPh3)2, X-phos, K2CO3, 
DMF-water (4/1, v/v), 120 °C. 
Scheme 26: Suzuki-Miyaura cross-coupling of 55 with arylboronic acids. 
 
Wipf and George, on the other hand, set out to achieve the sequential regioselective Pd-
catalyzed Suzuki cross-couplings of the 2,4,7-trichloroquinazoline 96 with arylboronic acids. 
The first coupling took take place at the most electrophilic C-4 position in low yield due to 
competitive hydrolysis at this site.
72
 The authors then decided to temporarily deactivate the 
C-4 position as thioether 97 to effect regioselective Suzuki-Miyaura cross-coupling with 
arylboronic acid derivatives at the C-2 position to afford 98, exclusively (Scheme 27).
72
 The 
C-4 position was then transformed via a palladium/copper(I)-mediated desulfitative coupling 
reaction by using excess copper(I) thiophene-2-carboxylate [Cu(TC)] and arylboronic acids to 
afford compounds 99. Finally, the cross-coupling at C-7 was effected using arylboronic acids 
to afford the trisubstituted quinazolines 100. 
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       100: Ar', Ar'', Ar''' = C6H5, 3-MeOC6H4, 4-EtC6H4 
Reagents and conditions: (i) propane-2-thiol, NaH, degassed THF, rt. (ii) Ar'B(OH)2, 
Pd(OAc)2, PPh3, Na2CO3, DME and H2O (10:1, v /v), 75 °C, N2. 
(iii) Ar''B(OH)2, Pd(PPh3)4, Cu(TC), THF, 50 °C, N2 
atmosphere. (iv) Ar'''B(OH)2, Pd(OAc)2, PPh3, Na2CO3, 
DME:H2O (10:1, v/v), reflux. 
Scheme 27: Regioselective Suzuki-Miyaura cross-coupling of 50. 
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1.3.3 Application of Negishi cross-coupling reactions in the synthesis of polysubstituted 
quinazolinones and/ or quinazolines  
 
Negishi cross-coupling reactions involve the cross-coupling of organozinc reagents (R‒ZnX) 
with aryl halides or heteroaryl halides in the presence of palladium species as a Pd(0) catalyst 
source (Scheme 28).
73
 The organozinc reagent can either be prepared from the corresponding 
halide R‒X by reductive metalation or via transmetalation of organolithium compounds (R‒
Li).
74
 The reaction frequently makes use of bis(triphenylphosphine)palladium(II) dichloride 
[PdCl2(PPh3)2] or 1,1'-bis(diphenyl-phosphino)ferrocene palladium dichloride [PdCl2(dppf)] 
as catalysts  and either diethyl ether or tetrahydrofuran (THF) as solvent.
75
 The advantage of 
this cross-coupling is that zinc compounds are relatively tolerant to many functional groups 
and the cross coupling is normally conducted at room temperature or slightly above because 
higher reaction temperatures can lead to degradation of the zinc compound. This reaction has 
also been employed for the synthesis of polycarbo-substituted quinazolines. 
R1
Pd(0) catalyst
Solvent
ZnX R2 X R1 R2
 
Scheme 28: General scheme for Negishi cross-coupling reactions. 
 
For example, palladium-catalyzed Negishi cross-coupling between quinazoline 101, 
methyllithium (CH3Li) and zinc(II) chloride (ZnCl2) afforded compound 102 (Scheme 29).
76
 
It is presumed that the reaction between CH3Li and ZnCl2 produces CH3‒ZnCl reagent which 
then undergoes cross-coupling with compounds 101. Of interest, compounds 102 were found 
to be phosphodiesterase inhibitors. 
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         101               102: R = 3,5-dibenzyloxy-phenyl;  
3,5-diisopropyloxy-phenyl;    
3,5-dicyclopropylmethyloxy-phenyl  
Reagents and conditions: MeLi, ZnCl2, Pd(PPh3)4, dioxane, 60 min. 
Scheme 29: Negishi cross-coupling reaction of 55 with CH3‒ ZnCl. 
 
In another example, 2-bromopyridine was reacted with isopropylmagnessium chloride 
followed by addition of zinc chloride to afford 2-pyridylzinc chloride (2-PyZnCl).
77 
The latter 
was, in turn, subjected to the Negishi cross-coupling reaction with the 2-chloro-5-iodo-6,7-
dimethoxyquinazolin-4-amine 103 using palladium acetate-triphenylphosphine [Pd(OAC)2-
PPh3] catalyst complex in THF under reflux to afford the cross-coupled product 104 
(Scheme 30).
78 
However, due to proximity of the acidic N-H protons, protonation of 
organozinc intermediate occurred giving rise to reduced product 105. When compound 103 
was treated with 2-iodopyridine in the presence of activated zinc and Pd(OAc)2–PPh3 mixture 
in DMF, compound 105 was obtained as a sole product.
78  
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Reagents and conditions: (i) 2-PyZnCl, Pd(OAC)2, PPh3, THF, reflux. 
Scheme 30: Negishi cross-coupling reaction of the 2-chloro-5-iodo-6,7-dimethoxyquinazolin-
4-amine 57. 
 
1.2.4 Application of Sonogashira cross-coupling reactions for the synthesis of 
polysubstituted quinazolinone and/ or quinazoline derivatives  
 
Sonogashira cross-coupling procedure involves the alkynylation of aryl- and heteroaryl 
halides using terminal alkynes in the presence of Pd(0) sources such as PdCl2(PPh3)2, and 
copper(I) salt as co-catalyst in the presence of an amine base (eg., diethylamine,
 
pyrrolidine, 
or triethyl amine) or also as a solvent (Scheme 31).
79
 The reaction can also occur at room 
temperature or under relatively mild reflux conditions in the presence of inorganic bases and 
in various organic solvents.  
Rl
Pd(0)/ CuI catalysts
Solvent
R2 R1 R2X
 
Scheme 31: General scheme for the Sonogashira cross-coupling reactions. 
 
The Sonogashira cross-coupling reaction has also been employed extensively on halogenated 
quinazolinones and quinazolines to afford variously substituted alkynylated derivatives. In 
terms of example, the Sonogashira cross-coupling of compound 106 with 
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ethyl-2-(1-butanesulfonamido)pent-4-yn-l-oate in the presence of tetrakis(triphenylphosphine)
palladium(0) (Pd(PPh3)4) as a catalyst and copper(I) iodide (Cul) as a co-catalyst afforded 107 
with potential application as fibrinogen receptor antagonist (Scheme 32).
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Reagents and conditions: (i) Pd(PPh3)4, Cul, HNEt2, 40° C. 
Scheme 32: Sonogashira cross-coupling reaction of 106 with 2-(1-butanesulfonamido)pent-4-
ynoic acid. 
 
The Sonogashira cross-coupling reaction between 6-bromo-2,4-dichloroquinazoline 108 and 
terminal alkynes 109 catalysed by PdCl2(PPh3)2 as Pd(0) source and CuI as co-catalyst in 
triethylamine (NEt3), also favoured the cross-coupling at the most electrophilic C-4 position 
rather than the less activated C(6)‒Br bond (Scheme 33).81 
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     108         109      110 
Reagents and conditions: (i) PdCl2(PPh3)2, CuI, NEt3, rt. 
Scheme 33: Sonogashira cross-coupling reaction of 108 with 109. 
 
In another example, the Sonoghashira cross-coupling of the 2-aryl-6,8-dibromo-4-
chloroquinazolines 111 with terminal acetylenes such as 3-butyn-2-ol, phenylacetylene and 
2-pyridinylacetylene was found to undergo cross-coupling exclusively at 4-chloro atom to 
afford the 4-alkynyl-6,7-dibromoquinazolines 112 in 53–72% yield (Scheme 34).19 The 
observed selectivity was attributed to an α-nitrogen effect, which makes the C-4 position 
highly activated compared to the other positions bearing Cl or Br. 4-Alkynylated quinazoline, 
6,7-diethoxy-4-(4-phenylbut-1-ynyl)quinazoline, for example, was reported to be potent 
epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.
82 
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                   111                            112: R = 4-H, 4-F, 4-Cl, 4-OMe;  
R' = CH(OH)CH3, C6H5, 2-pyridyl 
Reagents and conditions: (i) R′C≡CH, Pd(PPh3)4, CuI, Cs2CO3, THF, rt., 24 h. 
Scheme 34: Site-selective Sonogashira cross-coupling of 111 with terminal alkynes. 
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1.3.5 Application of the Heck cross-coupling reactions in the synthesis of 
polysubstituted quinazolinones and/ or quinazolines  
 
The Heck cross-coupling reaction, which leads to the formation of alkenyl‐ and arylvinyl 
derivatives, involves a Pd‐catalyzed inter‐ or intra-molecular cross‐coupling reaction between 
organohalides or triflates with alkenes (Scheme 35).
83
 This reaction has been employed for 
the synthesis of polycarbo-substituted quinazolinones and quinazolines 
R1 R2 R1 R2
Pd (0)
X  
Scheme 35: General scheme for Heck cross-coupling reactions. 
 
In terms of an example of the application of this reaction on halogenated quinazolinones, 
iodoquinazolin-4(3H)-one 113 was cross-coupled with unprotected allyl amidines or 
guanidines 114 in the presence of palladium (II) acetate‒tri-(o-tolyl)phosphine catalytic 
mixture and triethylamine as base in acetonitrile under reflux to afford a series of the 6-vinyl 
substituted products 115 (Scheme 36).
84 
Compounds 115 were not obtained when either 
benzene or toluene was used in place of acetonitrile and this compound was isolated in low 
yield when palladium tetrakis(triphenylphosphine) [Pd(PPh3)4] was used as catalyst. Of 
interest, compounds 115 were found to be potent vitronectin receptor (ανβ, integrin) 
antagonists.
84 
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Reagents and conditions: (i) Pd(OAc)2, (o-tolyl)3P, NEt3, CH3CN, reflux. 
Scheme 36: Heck cross-coupling of 113 with allyl amidines or guanidines. 
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In another example, the Heck cross-coupling reaction of N-[4-(6-methylpyridin-3-yloxy)-3-
methylphenyl]-6-iodoquinazolin-4-amine 116 and N-allyl-2-methoxyacetamide 117, catalysed 
by  tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3) in the presence of triethylamine as a 
base in 2-propanol as a solvent,  afforded N-[(E)-3-{4-[4-(6-methylpyridin-3-yloxy)-3-
methylphenylamino]quinazolin-6-yl}allyl]-2-methoxyacetamide 118 (Scheme 37).
85
 
Compound 118 is a selective ErbB2 angiogenesis inhibitor and is under investigation for the 
treatment of breast, ovarian and other types of cancer.
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Reagents and conditions: (i) Pd2(dba)3 (5 mol %), 2-propanol: Et3N (10:1, v/v) 
Scheme 37: The Heck cross-coupling reaction of 116 and 117 to afford 118. 
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2-(Furan-2-yl)-6-iodo-N-isopropylquinazolin-4-amine 119 was subjected to Heck cross-
coupling reaction with tert-butyl acrylate or 2-methylbut-3-en-2-ol by employing Pd(OAc)2–
tri-o-tolylphosphine complex and triethyl amine in acetonitrile at 100 °C to afford the 6-
alkynyl-4-(isopropylamino)quinazolin-6-yl)acrylates 120a and 120b in 63% and 86% yield, 
respectively (Scheme 38).
86 
Under the same reaction conditions, N-(3-fluorophenyl)-6-
iodoquinazolin-4-amine was coupled with 2-methylbut-3-en-2-ol to afford the 6-alkynylated 
derivative in 73% yield.
87
Compunds 120 were further subjected to bio-assays and were found 
to be 
 
selective inhibitors of Aurora A versus Aurora B.
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           119                                                                120: R = -CH3 (a); -OH (b) 
Reagents and conditions: (i) alkene, NEt3, Pd(OAc)2, (o-Tol)3P, acetonitrile, 100 °C. 
Scheme 38: Heck cross-coupling of 6-iodo-4-(isopropylamino)quinazolin-6-yl)acrylates 119 
with alkenes. 
 
1.3.6 Application of the Stille cross-coupling reactions in the synthesis of 
polysubstituted quinazolinones and/ or quinazolines  
 
The Stille cross-coupling of organostannanes with aryl halides/triflates
88
 depicted in Scheme 
39 makes use of tetrakis(triphenylphosphine)palladium(0) (Pd(PPh3)4) as catalyst in solvents 
such as tetrahydrofuran, toluene or dimethylformamide (DMF). The Stille cross-coupling, 
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however, requires a higher temperature to facilitate the transmetalation step from the weakly 
nucleophilic stannane to the intermediate arylpalladium halide.
89 
R1
Pd(0) catalyst
Solvent, heat
Sn R2 X R1 R2
 
Scheme 39: General scheme for the Stille cross-coupling reactions. 
 
This reaction has thus far only been employed on halogenated quinazoline derivatives. For 
example, the Stille cross-coupling between compound 121 and the organostannane reagents in 
the presence of Pd(PPh3)2Cl2 as a catalyst in xylene readily afforded compounds 101 in good 
yields (Scheme 40).
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                                                121        101: R = 3,5-dibenzyloxyphenyl; 
        3,5-diisopropyloxyphenyl; 
                                                                                            3,5-dicyclopropylmethyloxyphenyl  
Reagents and conditions: R‒SnBu3, (PPh3)2PdCl2, xylene, 110 °C. 
Scheme 40: Stille cross-croupling reaction of 121 with R‒SnBu3. 
 
The Stille cross-coupling of 5-chlorotriazoloquinazoline 122 with heteroarylstannanes in the 
presence of Pd(PPh3)4-CuI catalyst mixture and in DMF at 70 °C, on the other hand, afforded 
a series of 5-heteroaryl-substituted triazoloquinazolines 123 in 20–78% yields (Scheme 41).90 
In addition, the same reaction conditions were employed for the reaction of the analogous 5-
tosyltriazoloquinazoline with heteroarylstannanes to afford the corresponding 5-heteroaryl-
substituted derivatives in reasonable yields.
90
 The main drawback of the Stille cross-coupling 
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reaction is the toxicity of the tin compounds used. Moreover, their low polarity makes them 
poorly soluble in water for disposal. 
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   122                   123: Het = 2-Thienyl, 2-Furyl, 2-Pyridyl 
Reagents and conditions: (i) Het-SnBu3, Pd(PPh3)4, DMF, 70 °C. 
Scheme 41: Stille cross-coupling of 5-chlorotriazoloquinazoline 122 with heterarylstannanes. 
 
In general, the metal-catalyzed cross-coupling reactions serve to increase the degree of 
conjugation around the heterocyclic framework by attaching substituents with π-conjugative 
effect (eg. aryl and heteroaryl groups) either directly or through C–C double or triple bond to 
afford derivatives with interesting biological and/ or photophysical properties. 
 
1.4 Synthesis of bis-heterocyclic compounds  
 
Recently, bis-heterocyclic compounds have attracted attention in synthetic organic chemistry. 
For example, Kode et al. reported that bis-heterocylic compounds possess high sensitivity 
against many cancer cell lines such as breast cancer cells and leukemia cells.
91
 The authors 
synthesized 9-{[(2,6-dichloro-9H-purin-9-yl)methyl]benzyl}-2,6-dichloro-9H-purines 126 
from the reactions of dichloropurines 124 and dichloroxylenes (ortho, meta, or para) 125, in 
the presence of cesium carbonate (Cs2CO3) as a catalyst in DMSO (Scheme 42). The 
biological property studies of compounds 126 showed that 9-{o-[(2,6-dichloro-9H-purin-9-
yl)methyl]benzyl}-2,6-dichloro-9H-purine was  highly active against non-small lung cancer 
45 
 
NCI-H522 (GI50 3.39 µM) and several breast cancer MCF-7, HS 578T, T-47D (GI50 1.55, 
3.09, 2.19 µM) cell lines. 9-{m-[(2,6-Dichloro-9H-purin-9-yl)methyl]benzyl}-2,6-dichloro-
9H-purine was found to be active against leukemia CCRF-CEM, K562, MOLT-4, RPMI-
8226 (GI50 1.41, 1.95, 1.66 and 0.55 µM), colon cancer COLON 205 (GI50 3.38 µM), and 
several breast cancer MCF-7, T-47D (GI50 3.63, 3.02 µM, respectively) cell lines. Finally, 9-
{p-[(2,6-Dichloro-9H-purin-9-yl)methyl]benzyl}-2,6-dichloro-9H-purine was highly active 
against non-small lung cancer EKVX, colon cancer HT-29, melanoma SK-MEL-28, renal 
cancer RXF 393, prostate cancer DU-145 and several breast cancer HS 578T and BT-549 cell 
lines. 
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Reagents and conditions: (i) Cs2CO3, DMSO, rt. 
Scheme 42: Alkylation of 124 with 125 to afford compounds 126 
 
There has been growing interest in the synthesis of novel bis-quinazolinones in which the two 
quinazolinone moieties are linked together through a carbon chain
24
 or aryl group.
92-94
  For 
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example, stoichiometric amounts of isatoic anhydride 28 (2 equiv.), primary amines 127 (2 
equiv.) and dialdehydes 128 (1 equiv.) were condensed using p-toluenesulfonic acid 
(p-TsOH) as catalyst in ethanol or water under reflux to afford novel bis-2,3-
dihydroquinazolin-4(1H)-one 129 [Scheme 43 (i)].
92
 Molecular iodine was also employed as a 
catalyst in the reaction of isatoic anhydride 28 (2 equiv.) and primary amines 127 (2 equiv.) 
with dialdehydes 128 in 1-butyl-3-methylimidazolium bromide ([BMIm]Br) and the bis-2,3-
dihydroquinazolin-4(1H)-one derivatives 129 were obtained [Scheme 43 (ii)].
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Reagents and conditions: (i) p-TsOH, EtOH or H2O reflux. (ii) ) I2, [BMIm]Br, 50 °C 
Scheme 43: Condensation of compound 28 with primary amines 127 and dialdehydes 128. 
 
Moreover, molecular iodine was again used as a catalyst to condense isatoic anhydride 28 
with diamines 130 and in the presence of carbonyl compounds 131 in [BMIm]Br, to afford 
bis-dihydroquinazolin-4(1H)-one derivatives 132 (Scheme 44).
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Reagents and conditions: (i) I2, [BMIm]Br, 50 °C.   
Scheme 44: Condensation of 28 with diamines 130 and aldehydes or ketones 131. 
 
In another example, 2-pyridinyl-3,1-benzoxazinones 133 (2 mol equiv.) was reacted with one 
mole of 1,4-phenylenediamine 134 in glacial acetic acid and under reflux to afford the bis-
quinazolin-4(3H)-ones 135 (Scheme 45).
94
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Scheme 45: Condensation of compound 133 with diamine 134 to afford bis-quinazolin-(3H)-
one 135. 
 
Lu et al., recently reported a convenient method for the synthesis of bis-heterocycles 
incorporating both the 2,3-dihydroquinazolin-4(1H)-ones and the quinazolin-4(3H)-ones 
linked together by an aliphatic carbon.
24
 The authors condensed two moles of 2-
aminobenzamide 17 with 1,3-cyclohexanedione 136 using iodine in toluene under reflux 
(Scheme 46).  The first step in this reaction involves the condensation of 2-aminobenzamide 
17 with 1,3-cyclohexanedione 136, promoted by molecular iodine to form intermediate (I) 
with the liberation of water. Prototropic shift on (I) then occurs to afford intermediate (II). 
Intermediate (II) is then converted to (III) by intramolecular Michael addition of the amide 
nitrogen onto the enone carbon. Dehydrogenation between N(2)‒C(3) then occurs, followed 
by ring opening to form intermediate (IV). Likewise, another mole of 2-aminobenzamide 17 
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reacts with keto carbon on the open chain of intermediate (IV) leading to the formation of 
137. 
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Scheme 46: Proposed mechanism for condensation of anthranilamide 17 with cyclohexane-  
 1,3-dione 136. 
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1.5 Research hypothesis  
 
The 2,3-dihydroquinazolin-4(1H)-one
16 
and quinazolin-4(3H)-one
17 
derivatives were found to 
exhibit interesting electronic absorption and emission properties in solution. For example, the 
absorption and emission spectra of 2-tert-butyl-2,3-dihydro-3-phenylquinazolin-4(1H)-one 
acquired in chloroform revealed that this compound absorbs at λab 344 nm and it emits at 
λem 409 nm.
16 
On the other hand, 2-(4-methoxystyryl)-3-phenylquinazolin-4(3H)-one was 
found to absorb in the ultra-violet region λab 348 nm and emit in the visible region at 
λem 485 nm in acetonitrile.
18
 We envisioned that by linking quinazolin-4(1H)-one and 
quinazolin-4(3H)-one moieties together through an aliphatic chain and attaching aryl groups 
to the fused benzo rings of the resultant bis-heterocyclic compounds could impart some 
interesting photophysical properties. In our view, by attaching the aryl groups on the two 
quinazolinone moieties could modify the electronic absorption and emission properties of the 
resultant polyaryl-substituted bis-heterocycles further. The two frameworks linked together by 
an inert aliphatic chain could either enhance or quench the absorption and/ or emission 
properties of the bis-heterocycle. To prove this hypothesis, we decided to investigate the 
possibility to extend the method of Lu et al.
24
 to prepare polyaryl-substituted bis-heterocycles 
comprising the 2,3-dihydroquinazolin-4(1H)-one and 2,3-dihydroquinazolin-4(1H)-one 
moieties linked by aliphatic chain. We envisioned that 2-aminobenzamide 17 could be 
brominated and the resultant bromo derivative 138 could, in turn, be condensed with 
cyclohexane-1,3-diones 139 to afford the requisite bromo-substituted bis-heterocyclic 
compounds 140 comprising the halogenated 2,3-dihydroquinazolin-4(1H)-one and 
quinazolin-4(3H)-one moieties linked together by a carbon chain (Fig. 8). In our view, the 
presence of bromine atoms on the envisioned bis-heterocycles would enable further 
transformation via metal-catalysed cross-coupling reactions to afford novel polyaryl 
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substituted bis-heterocycles 141 with potential photophysical properties. The aryl groups are 
expected to impart a high degree of conjugation with electron-deficient 
dihydroquinazolin-4(1H)-one and quinazolin-4(3H)-one backbones. This, in turn, would 
enhance the donor-π-acceptor properties of the resultant polyaryl- or polyalkenyl derivatives. 
N
NH
N
H
HN
R''
R
R'
O O
N
NH
N
H
HN
R''
R
R'
O O
NH2
NH2
O
NH2
NH2
O
141
140
138 17139
O
R''
OR'
R
Ar Ar
Br Br
Br
Figure 8: Possible retrosynthetic route to compounds 141. 
 
With the above hypothesis in mind, we decided to investigate the synthesis of bis-heterocyclic 
systems comprising of 2,3-dihydroquinazolin-4(1H)-one and quinazolin-4(3H)-one moieties 
linked together by a carbon chain, based on the condensation of brominated 
2-aminobenzamide with cylcohexane-1,3-diones. The main goal was to prepare novel 
polyaryl substituted bis-heterocycles and to probe them for potential photophysical properties 
using UV-Vis and emission spectroscopic techniques. We opted for the use of the Suzuki-
Miyaura cross-coupling reaction with arylboronic acids to produce novel polyaryl substituted 
derivatives. In our view, the Kumada cross-coupling which could serve as an alternative for 
arylation would not be suitable for this transformation because the Grignard reagents would 
attack the base-sensitive amine and the electrophilic amide groups. The toxicity of organotin 
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compounds, on the other hand, hampered the use of Stille cross-coupling in this investigation. 
With these considerations, we decided on the following structured aims and objectives. 
 
1.6 Aims and objectives  
  
(i) To synthesize polybrominated bis-heterocycles comprising of 2,3-dihydroquinazolin-
4(1H)-one and quinazolin-4(3H)-one moieties based on 2-amino-3,5-dibromobenzamide 
and cylcohexanediones as precursors, 
(ii) To subject the resultant halogenated bis-heterocycles to the Suzuki-Miyaura cross-
coupling with arylboronic acids, 
(iii) To study the photophysical properties (absorption and emission) of the resultant polyaryl 
substituted bis-heterocycles by the use of electronic absorption and emission 
spectroscopic techniques. 
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CHAPTER 2:  RESULTS AND DISCUSSION  
 
The reaction of commercially available 2-aminobenzamide 17 with N-bromosuccinimide in 
acetic acid at room temperature afforded 2-amino-3,5-dibromobenzamide 142. This was 
followed by condensation with 1,3-cyclohexanedione derivatives 143a‒d in the presence of 
iodine as catalyst in toluene under reflux to afford novel halogenated bis-heterocycles    
144a–d. The latter were, in turn, subjected to Suzuki-Miyaura cross-coupling reactions with 
substituted arylboronic acids to produce polyaryl-substituted derivatives 145a‒l (Scheme 47). 
All the compounds were characterised by NMR (
1
H and 
13
C) and infrared (IR) spectroscopic 
techniques and their exact molecular formulae were confirmed by high-resolution mass 
spectroscopy. To understand the influence of substituents on intramolecular charge transfer 
(ICT) for the compounds 144a‒d and 145a‒l, we determined their absorption and emission 
properties in dimethylsulfoxide (DMSO) and acetic acid by UV/Vis and fluorescence 
spectroscopic techniques. 
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Reagents and conditions: (i) NBS (2 mmol equiv.), AcOH, 3 h, rt. (ii) I2, toluene, reflux; (iii) 
ArB(OH)2, K2CO3, PdCl2(PPh3)2, PCy3, dioxane-water(3:1, v/v), 
100 °C. 
Scheme 47: Generalized Scheme for the synthesis of polyaryl-substituted bis-heterocycles 
described in this investigation 
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2.1      Synthesis and transformation of halogenated bis-heterocycles  
 
The main aim of this work was to synthesize the novel bis-heterocycles comprising electron 
deficient 2,3-dihydroquinazolin-4(1H)-one and quinazolin-4(3H)-one moieties as electron-
acceptors each linked directly to the aryl groups at the 6- and 8-position to comprise a donor-
π-acceptor system. In order to realise our goal we required brominated 2-aminobenzamide as 
a precursor and that was obtained by the reaction of 2-aminobenzamide with 
N-bromosuccinimide. The results are discussed in detail below. 
 
2.1.1 Synthesis of 2-amino-3,5-dibromobenzamide 142  
 
Aniline derivatives were previously brominated by using molecular bromine in the presence 
of transition metal-based catalysts such as iron(III) bromide.
95
 However, this reaction 
generates the corrosive and toxic hydrogen bromide. On the other hand, bromine is not 
selective and was found to form a mixture of mono-, di-, tri-, and even tetra-brominated 
aniline derivatives.
96
 The 2-amino-3,5-dibromobenzamide 142 used in this investigation as a 
precursor was previously prepared from the commercially available 2-aminobenzamide and 
N-bromosuccinimide (NBS) (2.5 equiv.) in chloroform-carbon tetrachloride mixture (3/2, 
v/v).
70
 However, in this study we found that acetic acid worked well as a solvent at room 
temperature and produced comparable yield (78%) to that obtained using chloroform-carbon 
tetrachloride mixture. The reaction of 2-aminobenzamide 17 with NBS in acetic acid at room 
temperature readily afforded 2-amino-3,5-dibromobenzamide 142  (Scheme 48). The 
1
H NMR spectrum compared well with the literature spectrum
70
 by revealing the presence of 
proton signals in the aromatic region H 6.5‒8.5 ppm with the protons of the amide group 
showing as a broad singlet at H 6.80 ppm in accordance with the literature precedents.
97 
The 
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amine protons displayed diastereotopic effect and they resonate at H 7.47 ppm and 
H 8.05 ppm. This non-equivalence of the amine protons is caused by intramolecular 
H-bonding between the proton at 8.05 ppm and amide oxygen in analogy with literature 
precedents.
97 
The two doublets at H 7.72 ppm and H 7.77 ppm, with coupling constant 
values of J = 2.4 Hz and J = 2.1 Hz correspond to 4-H and 6-H, respectively. 
NH2
O
NH2
NH2
O
NH2
Br
Br
 (i)
 
           17              142 (78%) 
Reagents and conditions: (i) NBS (2.0 mmol equiv.), acetic acid, rt, 3 h. 
Scheme 48:  Bromination of 2-aminobenzamide 17 with NBS.  
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Figure 9: 
1
H NMR spectrum of 2-amino-3, 5-dibromobenzamide 142 in DMSO-d6 at 300 MHz.
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With 2-amino-3,5-dibromobenzamide 142 in hand, we decided to investigate its reactivity 
with cyclohexane-1,3-dione derivatives with the aim to prepare halogenated bis-heterocycles. 
 
2.1.2 Synthesis of 6, 8-dibromo-2-[3-(2'-alkyl- 6', 8'-dibromo-1', 2', 3', 4'-tetrahydro-4'-
oxoquinazoline-2'yl)propyl]quinazolin-4(3H)-ones (144a‒d)  
 
In this investigation, we opted for the method previously described by Lu et al., which 
involves the condensation of 2-aminobenzamide with cyclohexane-1,3-dione 143 in the 
presence of iodine as a catalyst in toluene under reflux.
24
 The initial use of 2.0 mol equiv. of 
142 with 1.0 equiv. of 143a catalysed by iodine in toluene under reflux afforded the targeted 
bis-heterocycle 144a in low yield (40%). This prompted us to use a slight excess amount of 
142 (2.2 mmol) with 1.0 equivalent of derivatives 143a and to our delight, within 5 hours (tlc 
monitored), we isolated compound 144a in high yield (85%) by just filtration and 
recrystallization from ethanol (Scheme 49). These reaction conditions were extended to 
substrates 143b‒d to study the effects of substituent(s) on 2nd and 5th position of cyclohexane-
1,3-dione on the yields and reaction times. Relatively high yield (83%) was observed when 5-
methylcyclohexane-1,3-dione 143b was used as substrate, however, it involved prolonged 
reaction time (12 h) than cyclohexane-1,3-dione 143a. The use of 2-methyl-substituted and 
5,5-dimethylcyclohexane-1,3-dione as substrates afforded after 24 h the corresponding 
products in 60 and 63% yield, respectively. Prolonged reaction time and reduced yields are 
presumably due to steric hindrance caused by the methyl groups. The resultant halogenated 
bis-heterocycles   144a‒d were characterized using a combination of NMR (1H and 13C), and 
IR as well as mass spectroscopic techniques. The 
1
H NMR spectra of compounds 144a‒d 
revealed the presence of groups of multiplets in the aliphatic region corresponding to the 
substituted propyl chain. The methylene protons of compound 144c are diastereotopic with 
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large germinal coupling constants 
2
J ca. 13.5 Hz and 15.3 Hz. This observed diastereotopicity 
of methylene protons is probably due to their position relative to the two non-equivalent 
methyl groups on the position 2 of the propyl linkage. Only four singlets were observed in the 
aromatic region corresponding to the protons of the fused benzo rings. The other three 
singlets at H ca. 6.0 ppm, 8.0 ppm, and 12.0 ppm correspond to 1'‒NH, 3'‒NH, and 3‒NH, 
respectively. The formation of halogenated bis-heterocycles 144a‒d was further confirmed by 
the presence of 
13
C signals in the aliphatic region corresponding to propyl carbons, as well as 
increased number of 
13
C signals in the aromatic region of the 
13
C NMR spectra. 
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144 R R´
 
R´´ Time (h) % Yield Melting point (°C) 
144a H H H 5 85 286‒290 
144b CH3 H H 12 83 312‒314 
144c CH3 CH3 H 24 63 315‒318 
144d H H CH3 24 60 307‒310 
 
Reagents and conditions: 142 (2.2mmol), 143 (1mmol), (i) I2 (15% of 142), toluene reflux 
Scheme 49: Condensation of compound 142 with 143a‒d. 
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Figure 10: 
1
H NMR spectrum of 6,8-dibromo-2-[3-(6',8'-dibromo-1',2',3',4'-tetrahydro-2'-methyl-4'-oxoquinazolin-2'-yl)propyl]quinazolin-
4(3H)-one 144a in DMSO-d6 at 300 MHz. 
3-NH 
1'-NH 
3´-NH 
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The presence of bromine atoms in compounds 144a‒d makes them suitable candidates for 
further studies of chemical transformation via metal-catalysed cross-coupling reactions to 
afford the novel polycarbo-subtituted derivatives. For example, the 6,8-dibromo 
bis-heterocycles 144a‒d could be subjected to Kumada cross-coupling with 
organomagnesium compounds,
62
 Suzuki cross-coupling with organoboronic acids,
67
 Negishi 
cross-coupling with organozinc reagents,
73
 Sonogashira cross-coupling with terminal 
alkynes,
79
 Heck cross-coupling with alkenes
83
 or Stille cross-coupling with organostannane 
compounds
87
 to afford polycarbo-substituted bis-heterocycles. Our aim is to prepare the bis-
heterocycles comprising the electron deficient 2,3-dihydroquinazolin-4(1H)-one and 
quinazolin-4(3H)-one moieties as electron-acceptors attached to the aryl groups as π-electron 
donors to comprise donor-π-acceptor systems. The aryl groups attached to an electron-
deficient heterocyclic framework have been found to shift the π‒π* transition towards the 
visible region.
25 
Consequently, we decided to study the photophysical properties (electronic 
absorption and emission) of compounds 144a‒d and 145a‒l in solution using UV-Vis and 
emission spectroscopic techniques. In order to realise our goal and to attach the aryl groups to 
the bis-heterocyclic compounds, we decided to employ the Suzuki-Miyaura cross coupling 
reaction of halogenated bis-heterocycles 144a‒d with arylboronic acids as coupling partners. 
The choice over alternatives such as Stille- and Kumada cross-coupling reactions was 
influenced by the ready availability of organoboronic acids compounds and their ability to 
tolerate a wide range of functional groups as well as easy work-up.
70
 The Stille cross-
coupling, for example, makes use of the toxic organotin compounds, which are less polar and 
therefore poorly soluble in some organic solvents. On the other hand, the Kumada cross-
coupling reaction uses the highly basic and nucleophilic Grignard reagents, which could 
attack the amide groups or deprotonate them thus complicating the outcome of the reaction. 
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2.1.3 Suzuki-Miyaura cross-coupling reactions of halogenated bis-heterocycles 144a‒d 
with arylboronic acids  
  
The Suzuki-Miyaura cross-coupling of analogous 6,8-dibromoquinazolin-4(1H)-ones with 
arylboronic acids in the presence of bis(triphenylphosphine)palladium(II) dichloride 
(PdCl2(PPh3)2) as catalyst and potassium carbonate as a base in aqueous 
N,N-dimethylformamide was conducted before.
70
 However, a complex mixture of products 
was obtained, and that prompted the authors to use an alkylphosphine ligand which  is known 
to coordinate with palladium and increase its electron density, and consequently accelerate the 
oxidative addition and reductive elimination steps in the catalytic cycle.
70
 With the literature 
precedents in mind and as a preliminary study, we reacted 6,8-dibromo bis-heterocycle 144a 
(1.0 equiv.) with phenylboronic acid (4.0 equiv.) in the presence of PdCl2(PPh3)2 as a catalyst, 
tricyclohexylphosphine (PCy3) as a ligand and potassium carbonate (K2CO3) as a base in 
dioxane-water at 100 °C. However, the reaction led to the formation of complex mixture of 
products which could not be separated by column chromatography due to similar Rf values. 
The previous literature results for the Suzuki-Miyaura cross-coupling reactions of the 
analogous 4-alkynyl-2-aryl-6,8-dibromo-quinazolines
19 
bearing two bromine atoms on the 
fused benzo ring revealed that these cross-couplings occur without selectivity presumably due 
to comparable C‒Br bond strength. Computational studies on bond dissociation energies at 
B3LYP and G3B3 levels revealed that all of the positions on the fused benzo ring of various 
heterocycles bearing identical halogen atoms have comparable carbon-halogen (X = Br, Cl) 
bond dissociation energies.
71
 As a result, the cross-coupling reactions involving dihalogenated 
heterocycles bearing identical halogen atoms are usually conducted using an excess of the 
coupling partner to drive the reaction to completion.
97
 In analogy with these literature 
precedents, we decided to subject the 6,8-dibromo bis-heterocycles 144a  to Suzuki-Miyaura 
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cross-coupling with an excess of phenylboronic acid (4.5 equiv.) in the presence of 
PdCl2(PPh3)2-PCy3 catalyst complex and potassium carbonate as a base in aqueous dioxane at 
100 °C. We again isolated a complex mixture of products. We then employed 5.0 equivalent 
of phenylboronic acid with bis-heterocycle 144a (1.0 equiv.) and after the completion of the 
reaction (tlc monitoring) we isolated polyaryl-substituted derivative 145a in high yield (80%) 
by recrystallization with mixture of ethyl acetate and n-hexane. These reaction conditions 
were extended to substrates 144b‒d with phenylboronic, 4-methoxyphenylboronic and 
4-fluorophenylboronic acids (5.0 equiv.) as coupling partners to afford the polyaryl-
substituted derivatives 145a‒l in high yields (60–81%) and high purity without a need for 
column chromatography. Compounds 145a‒l were characterised by NMR spectroscopy (1H 
and 
13
C), IR, and mass spectroscopy techniques. The resultant polyaryl-substituted derivatives 
145a‒l were distinguished from the corresponding precursors by the presence of an increased 
number of protons in the aromatic region δH (6.5‒8.5 ppm).  The NMR spectra of the 
methoxyphenyl-substituted derivatives 145c, 145f, 84i and 145l revealed the presence of four 
singlets in the region δH 3.5‒3.8 ppm (OCH3) and four carbon peaks in the region δC 54‒56 
ppm (OCH3) thus confirming complete substitution of the four bromine atoms. The 
replacement of bromo atoms by 4-fluoroaryl groups, on the other hand, was confirmed by the 
presence of 
13C NMR signals at δC 161.0‒163.0 ppm (4 x 
1
JCF ca. 24.0 Hz), δC 115.0‒116.5 
ppm (4 x 
2
JCF ca. 21.0 Hz), δH 128.0‒133.0 ppm (4 x 
3
JCF ca. 8.0 Hz) and δC 134.5‒137.0 ppm 
(4 x 
4
JCF ca. 3.0 Hz). Furthermore, the absence of the bromine isotopes (
79
Br and 
81
Br) in the 
molecular ion peaks in the mass spectra of these compounds confirmed complete replacement 
of the bromo atoms by the aryl groups (see selected mass spectra under appendix). The 
absence of carbon-bromine bands in the region 515‒690 cm-1 of their IR spectra, on the other 
hand, further confirmed complete substitution of the halogen atoms by the aryl groups. It was 
difficult to assign the 1-H and C-13 chemical shifts to their corresponding nuclei due to 
64 
 
increased number of proton and carbon signals in the NMR spectra of the resultant polyaryl-
substituted derivatives   145a‒l.  
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Compound R R´ R´´ Ar Time (h) %Yield 
Melting point 
(°C) 
145a H H H C6H5 4 80 203‒206  
145b H H H 4-FC6H4 4 81 241‒243  
145c H H H 4-MeOC6H4 4 74 181‒184  
145d CH3 H H C6H5 4 75 211‒215  
145e CH3 H H 4-FC6H4 4 70 265‒268 
145f CH3 H H 4-MeOC6H4 4 73 194‒196  
145g CH3 CH3 H C6H5 4 76 289‒292  
145h CH3 CH3 H 4-FC6H4 4 77 303‒305  
145i CH3 CH3 H 4-MeOC6H4 4 81 228‒230  
145j H H CH3 C6H5 4 63 223‒226  
145k H H CH3 4-FC6H4 4 63 252‒254 
145l H H CH3 4-MeOC6H4 4 60 192‒195  
 
Reagents and conditions: (i) ArB(OH)2 (5.0 mmol equiv.), K2CO3 (4.5 mmol equiv.), 
PdCl2(PPh3)2, (10% of 144), PCy3 (20% of 144), and dioxane-
water (3:1, v/v), 100 °C. 
Scheme 50: Suzuki-Miyaura cross-coupling of 144a‒d with arylboronic acids. 
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Figure 11: 
1
H NMR spectrum of 2-{3-[2-ethyl-1,2,3,4-tetrahydro-6,8-bis(4-methoxyphenyl)-4-oxoquinazolin-2-yl]propyl}-6,8-bis(4-
methoxyphenyl)quinazolin-4(3H)-one 145l in DMSO-d6  at 300 MHz. 
3-NH 
1´-NH 
4 x -OCH3 
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Figure 12: 
13
C NMR spectrum of 2-{3-[1',2',3',4'-tetrahydro-6',8'-bis(4-methoxyphenyl)-2'-methyl-4'-oxoquinazolin-2-yl]-2'-methylpropyl}-6,8-
bis(4-methoxyphenyl)quinazolin-4(3H)-one 145f in DMSO-d6 at 75 MHz. 
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The prepared polyaryl-substituted bis-heterocycles 145a–l contain electron-deficient 
2,3-dihydroquinazolin-4(1H)-one and quinazolin-4(3H)-one moieties as electron-acceptors, 
each linked directly to the 4-substituted aryl ring to comprise a donor-π-acceptor system. It 
was envisioned that the presence of 4-substituted aryl-substituents would enhance the 
electronic absorption and emission properties of the resultant polyaryl-substituted bis-
heterocycles towards visible region in analogy with literature precedents.
25
 To prove this 
hypothesis and in order to understand the influence of substituents on intramolecular charge 
transfer (ICT), we measured the absorption and emission spectra of compounds 144a–d and 
145a–l in solution using UV/Vis and emission spectroscopic techniques. 
 
2.2 Absorption and emission property studies of halogenated bis-heterocycles   
(144a–d) and polyaryl-substituted bis-heterocycles (145a‒l)  
 
2.2.1 Absorption properties of halogenated bis-heterocycles (144a‒d)  
 
We first measured the absorption properties of bis-heterocycles 144a–d in DMSO at room 
temperature (concentration 5 x 10
-5
 M). DMSO was chosen as the solvent for this purpose 
because of poor solubility of these compounds in other solvents. The absorption property 
results of the bis-heterocycles 144a–d are listed in Table 1. The bis-heterocycles 144a–d 
show similar absorption patterns and their spectra are characterised by four absorption bands, 
one intense band in the region λmax 275‒278 nm, two shorter bands at λmax ca. 325 and 339 nm 
and the fourth broad band at 360 nm (Fig. 13). According to literature reports, the intense 
absorption bands in the region λmax 275‒278 nm are due to n–π* transition of the carbonyl 
fragments and the π–π* transition caused by intramolecular charge transfer from phenyl ring 
and N═C–N fragments to carbonyl fragment.98 A significant red shift observed on the shorter 
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absorption bands for compounds 144a‒d at λmax ca. 325, 339 and 360 nm are probably due to 
the influence of the four bromine atoms on the electronic transitions within the phenyl rings. 
The substitution of the hydrogen atom(s) with methyl group(s) on position 2 of the propyl 
linkage and on methyl group on position 2 of the 2,3-dihydroquinazolin-4(1H)-one decrease 
the molar extinction coefficient in the order: 144a > 144d > 144b > 144c at shorter 
wavelengths (λmax 275‒278 nm). However, at higher wavelengths (λmax ca. 325, 339 and 360 
nm), the substitution of the hydrogen atom(s) with methyl group(s) on position 2 of the open 
chain and on methyl group of 144b and 144c have slight or no effect on the molar extinction 
coefficients. 
 
Figures 13: UV-Vis spectra of 144a-d in DMSO at rt. (conc. = 5 x10
-5
 mol/L) 
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Table 1: The absorption data for compounds 144a‒d. 
Compound 
λmax (nm) 
DMSO 
Molar extinction coefficient 
(ε) × 104 Mol–1 cm–1 
144a 275.8, 325.3, 338.8, 360.4 1.6, 0.5, 0.5, 0.3 
144b 276.1, 325.3, 338.8, 362.2 1.5, 0.5, 0.5, 0.3 
144c 277.0, 325.3, 339.1, 359.5 1.4, 0.5, 0.5, 0.3 
144d 277.9, 325.9, 338.8, 360.4 1.6, 0.4, 0.4, 0.2 
 
 
2.2.2 Absorption properties of polyaryl-substituted bis-heterocycles (145a‒l)  
 
Absorption spectra of polyaryl-substituted bis-heterocycles 145a‒l were acquired in DMSO 
(dashed lines) and acetic acid (solid lines) and their absorption results are listed in Table 2. 
These solvents were chosen due to poor solubility of these compounds in other solvents. 
Polyaryl-substituted bis-heterocycles 145 with phenyl- or 4-fluorophenyl groups on the fused 
benzo rings display similar absorption patterns in DMSO (dashed lines) and are characterised 
by intense absorption bands at λmax ca. 262 and 302 nm with comparable molar extinction 
coefficients (Fig. 14‒17). The absorption spectra of bis-heterocycles 145c, 145f, 145i, and 
145l bearing strong electron donating 4-methoxyphenyl groups on the fused benzo rings in 
DMSO, on the other hand, are characterized by broad intense bands at λmax ca. 291 nm. 
Compounds 145a‒l showed blue shifts in acetic acid (solid lines) with phenyl- or 
4-fluorophenyl-substituted derivatives displaying similar absorption patterns and their 
absorption spectra are characterized by two absorption maxima, one intense band in the 
regions λmax 255‒260 nm and one less intense band in the region λmax 283‒295 nm     
(Fig. 14‒17). The less intense wavelength bands are presumed to be caused by 
hydrogen-bonding between the hydroxyl group of acetic acid and carbonyl groups of 
2,3-dihydroquinazolin-4(1H)-one and quinazolin-4(3H)-one moieties. The 4-methoxyphenyl-
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substituted derivatives 145c, 145f, 145i, and 145l in acetic acid are characterized by weak 
absorption bands at lower wavelength maxima and broad intense bands at higher wavelength 
maxima. The absorption bands at λab ca. 302 nm in DMSO (dashed lines) and at                   
λab 283–295 nm in acetic acid (solid lines) are due to n–π* transition of the carbonyl 
fragments and to the π–π* transition caused by intramolecular charge transfer from phenyl 
ring and N═C–N fragment to carbonyl fragment in analogy with the literature assignments.98 
The observed broad absorption bands of the 6,8-bis(4-methoxyphenyl)-substituted bis-
heterocycles 145c, 145f, 145i, and 145l  in DMSO are presumably due to the overlap of the 
two absorption bands from π–π* transition from aryl substituents and from those of n–π* 
transition of the carbonyl fragments and the π–π* transition caused by intramolecular charge 
transfer from phenyl ring and N═C–N  fragments to carbonyl fragment. The strong electron 
donating methoxyphenyl groups are presumed to cause bathochromic effect (red shift) of the 
π–π* transition from aryl substituents resulting in the overlap of the two bands. The observed 
weak wavelength bands at λmax ca. 260 nm of 4-methoxyphenyl-substituted derivatives 145c, 
145f, 145i, and 145l in acetic acid, on the other hand, are probably due to H-bonding from 
hydroxyl group of acetic acid with methoxy groups and therefore slightly causing the blue-
shift of bands of π–π* transition from aryl substituents. The presence of electron-withdrawing 
fluoroaryl substituents was found to have little effect on shifting of the wavelength maxima. It 
was also observed that as the carbon chain joining the 2,3-dihydroquinazolin-4(1H)-one and 
quinazolin-4(3H)-one moieties becomes bulky, the molar extinction coefficients are reduced.  
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Figures 14: UV-Vis spectra of 145a-c in DMSO (dashed lines) and CH3CO2H (solid 
lines) at rt. (conc. = 1 x 10
-5
 mol/L) 
    
 
Figures 15: UV-Vis spectra of 145d-f in DMSO (dashed lines) and CH3CO2H (solid 
lines) at rt. (conc. = 1 x 10
-5
 mol/L) 
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Figures 16: UV-Vis spectra of 145g-i in DMSO (dashed lines) and CH3CO2H (solid 
lines) at rt. (conc. = 1 x 10
-5
 mol/L) 
 
 
Figures 17: UV-Vis spectra of 145j-l in DMSO (dashed lines) and CH3CO2H (solid lines) 
at rt. (conc. = 1 x 10
-5
 mol/L) 
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The observed electron absorption properties of compounds 144a‒d and 145a‒l prompted us 
to investigate their emission properties and the results are described below. 
 
2.2.3 Emission properties of halogenated bis-heterocycles (144a-d) and polyaryl-
substituted bis-heterocycles (145a‒l)  
 
The emission spectra of the halogenated bis-heterocycles 114a-d acquired in DMSO 
(concentration = 1 x 10
-5
 M) revealed the presence of bands of negligible intensity. This effect 
is presumably due to the presence of heavy bromine atoms.
99
 The analogous 8-benzyloxy-5,7-
dibromoquinoline  was reported to be non-fluorescent because its  S1 state is a π‒σ* excited 
state, where the LUMO is a σ*-orbital localized at the C–Br bonds.100 The photoluminescence 
spectra of the polyaryl-substituted bis-heterocycles 145a‒l were also acquired at room 
temperature in DMSO (dashed lines) and CH3CO2H (solid lines) at concentrations of 
1 x 10
-4 
M and excitation wavelength λex 370 nm (Figures 18‒21). The emission spectra of 
compounds 145a‒l displayed similar emission profiles and their spectra are characterized by 
single emission bands in the region λem 430‒450 nm in DMSO (dashed lines) and in the 
region λem 475‒505 nm in CH3CO2H (solid lines). These bands are due to π‒π* transition 
attributed to the conjugated quinazolinone scaffold. The emission spectra of compounds 145c, 
145f, 145i and 145l bearing the strong electron-donating 6,8-bis(4-methoxyphenyl)-
substituted groups are slightly red shifted in both DMSO and CH3CO2H as compared to those 
bearing phenyl- (145a, 145d, 145g, 145j) or 4-fluorophenyl groups (145b, 145e, 145h, 145k). 
The observed slight red shift is presumably due to activating methoxy groups which donate 
electrons to the aryl groups. Compounds 145a‒l exhibit bathochromic shift and low intensity 
emission bands in CH3CO2H than in DMSO (Fig. 18‒21). The observed red shift and the 
reduction in intensity of the emission bands are presumably the consequence of strong 
hydrogen-bonding between acetic acid and carbonyl groups of quinazolinone moieties, which 
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would reduce the electron density around carbonyl oxygens. This effect, in turn, would 
increase the Stokes shift and reduce the quantum yields values. As the carbon chain joining 
the 2,3-dihydroquinazolin-4(1H)-one and quinazolin-4(3H)-one moieties becomes bulky, the 
intensity of the emission bands decreases in DMSO (dashed lines), while in acetic acid (solid 
lines), the bulkiness of the carbon chain had no significant effect on the intensity of emission 
bands. Compounds 145g‒i with 2,2-dimethyl-substituted propyl groups were found to have 
reduced quantum yields as compared to compounds 145a‒f and 145j‒l which had comparable 
quantum yields with respect to the substituent on the aryl substituents. 
 
Figure 18: Emission spectra of 145a-c in DMSO (dashed lines) and CH3CO2H (solid lines) at 
rt. (conc. = 1 x 10
-4
 mol/L) 
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Figure 19: Emission spectra of 145d-f in DMSO (dashed lines) and CH3CO2H (solid lines) at 
rt. (conc. = 1 x 10
-4
 mol/L) 
 
 
Figure 20: Emission spectra of 145g-i in DMSO (dashed lines) and CH3CO2H (solid lines) at 
rt. (conc. = 1 x 10
-4
 mol/L) 
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Figure 21: Emission spectra of 145j-l in DMSO (dashed lines) and CH3CO2H (solid lines) at 
rt. (conc. = 1 x10
-4
 mol/L) 
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145 λmax 
(nm) 
DMSO 
(ε) x 104 
M
−1
cm
−1 
DMSO 
λmax (nm) 
CH3CO2H 
(ε)  x 104 
M
−1
cm
−1 
CH3CO2H 
λem (nm) 
DMSO 
λem (nm) 
CH3CO2H 
(a)
Quantum 
yields (Φ)  
x 10
-3
 
DMSO 
(a)
Quantum 
yields (Φ)  
x 10
-3
 
CH3CO2H 
Stokes 
shift 
DMSO 
Stokes shift 
CH3CO2H 
145a 
 
145b 
 
145c 
 
145d 
 
145e 
 
263.2 
302.5 
263.2 
300.1 
291.4 
 
263.2 
302.5 
263.5 
300.4 
4.2 
 
4.2
 
3.9 
3.6 
 
5.3
 
 
3.4 
 
3.2  
3.3 
 
3.2
 
255.1 
292.3 
255.4 
283.6 
258.1 
288.1 
257.5 
292.3 
257.8 
288.4 
5.5 
 
3.7 
 
4.7 
 
3.4 
 
4.4 
 
5.2 
 
4.6 
 
3.2 
 
4.5 
 
3.3  
438.0 
438.0 
439.0 
439.0 
448.0 
 
437.5 
437.5 
437.0 
437.0 
479.0 
479.0 
478.5 
478.5 
505.5 
505.5 
475.5 
475.5 
476.5 
476.5 
7.5 
 
7.5  
7.8 
 
8.3  
5.5 
 
 
8.0 
 
8.4 
 
7.7  
 
7.8  
 
2.6 
 
3.8  
 
2.0  
 
2.7  
 
2.0 
 
1.7  
 
2.8  
 
4.1  
 
2.4  
 
3.3   
174.8 
135.5 
175.8 
138.9 
156.6 
 
174.3 
135.0 
173.5 
136.6 
223.9 
186.7 
223.1 
194.9 
247.4 
217.4 
218.0 
183.2 
218.7 
188.1 
Table 2: The absorption and emission data for compounds 145a‒l. 
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(a) Obtained by calculation, based on the quinine sulfate in 1.0 N H2SO4 as the standard (Φq = 0.55).
101 
145f 
 
145g 
 
145h 
 
145i 
 
145j 
 
145k 
 
145l 
290.5 
 
262.0 
304.0 
262.6 
300.1 
293.3 
 
262.0 
303.4 
261.7 
302.2 
291.4 
4.8 
 
3.0 
 
3.0  
3.7  
3.7  
4.6
 
 
4.3 
 
3.9  
3.6  
3.6  
4.5 
 
257.2 
285.1 
254.8 
295.3 
254.8 
288.1 
259.6 
288.7 
257.8 
293.8 
257.5 
291.4 
259.0 
286.3 
4.7
 
5.2 
3.7 
 
2.7
 
5.2 
 
3.7 
 
4.2 
 
4.8  
3.9 
 
2.6 
 
4.6
 
3.3 
 
5.2  
5.8 
 
443.0 
 
434.5 
434.5 
436.0 
436.0 
447.5 
 
439.0 
439.0 
439.0 
439.0 
447.5 
504.0 
504.0 
477.5 
477.5 
477.0 
477.0 
502.0 
502.0 
481.5 
481.5 
484.5 
484.5 
505.0 
505.0 
5.4   
 
6.4  
 
6.4 
 
5.3  
 
5.3  
 
4.2  
 
 
8.2  
 
9.0  
 
9.1  
 
9.3  
 
6.8  
 
1.6  
 
1.5 
4.0  
 
5.5   
2.9  
 
4.2   
1.7   
1.5   
2.4  
 
3.6  
 
1.5  
 
2.1  
 
1.6
 
1.4  
 
152.5 
 
172.5 
130.5 
173.4 
135.9 
154.2 
 
177.0 
135.6 
177.3 
136.8 
156.1 
 
246.8 
218.9 
222.7 
182.2 
222.2 
188.9 
242.4 
213.3 
223.7 
187.7 
227.0 
193.1 
246.0 
218.7 
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2.2.4 Quantum Chemical Calculations  
 
We carried out a theoretical approach to establish the structural features and molecular 
orbitals of the bis-heterocycles 145a‒l, by means of density functional theory at the LC-
BLYP/6-31+G(d,p)
102 
level as implemented in Gaussian 09 suite.
103
 The reasonable structures 
for the electronic structure computations were obtained from geometries optimized at the LC-
BLYP/6- 31G(d,p) level in DMSO. The bulk solvent effects were included via the Polarisable 
Continuum Model (PCM), using the integral equation formalism variant (IEFPCM)
104
 in 
DMSO. The computed spectral profiles of compounds 145c, 145f and 145k in DMSO were 
chosen and their absorption spectra were reproduced at LC-BLYP level with three absorption 
peaks at λab ca. 235, 260 and 300 nm (Figure 22). Compounds 145c, 145f and 145k were 
chosen in order to reveal the effect of substituent on the para position of the 6- and 8-aryl 
groups and/ or the effect of substituent on propyl group on the electronic spectra. The 
experimental and computed wavelength maxima were found to be comparable to within an 
average error of ± 3 nm (Table 3). About 60% of the transfer band at λ ca. 300 nm can be 
attributed to an electronic transition from HOMO to LUMO+2 and approximately 20% is 
attributed to an electronic transition from HOMO-4 to LUMO+2. The electronic transitions 
from HOMO-1 to LUMO+1 (50%) and the other from HOMO-1 to LUMO (33%) give rise to 
absorption band at λab ca. 260 nm. The computed ground- and excited-state dipole moments 
were inspected using LC-BLYP functional and they confirmed that the first singlet excited 
state is rather of more polar character than the ground state (Table 3). The dipole moments of 
the excited state are slightly larger than those of the ground state by one debye. Similar results 
were obtained for these compounds presumably due to the highly symmetric molecular 
structure. 
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Figure 22. Computed absorption spectra of 145c, 145f and 145k. 
 
Table 3: The computed dipole moments and absorption spectra of compounds 415a–l. 
Compound Dground (Debye) Dexcited (Debye) λmax (nm) 
145a 7.66 8.24 260, 299 
145b 7.45 8.37 261, 300 
145c 5.96 5.44 266, 301 
145d 5.71 6.62 262, 301 
145e 9.84 9.92 261, 300 
145f 8.99 9.02 260, 304 
145g 5.62 6.07 262, 299 
145h 6.45 6.47 262, 298 
145i 5.81 5.94 260, 297 
145j 7.70 8.09 261, 299 
145k 8.19 8.33 262, 299 
145l 6.35 7.41 266, 301 
 
145c 
145k 
145f 
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Figure 23: Orbital topology for 145c as representative compound. 
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CHAPTER 3: CONCLUSIONS 
 
Bromination of 2-aminobenzamide with 2.0 equiv. of N-bromosuccinimide afforded 2-amino-
3,5-dibromobenzamide. The dibromination of 2-aminobenzamide is favoured by the 
combined ortho-para directing amino group and meta directing effect of the amide group. 
Iodine-promoted cyclisation of 2-amino-3,5-dibromobenzamide with 1,3-cyclohexanedione 
derivatives and subsequent in situ dehydrogenation of one the quinazolinone moieties to  
afford novel 6,8-dibromo-2-(3-(2´-alkyl-1´,2´,3´,4´-tetrahydro-6´,8´-dibromo-4´-
oxoquinazoline-2yl)propyl)quinazolin-4(3H)-ones. Suzuki-Miyaura cross-coupling of the 
latter with phenylboronic acid, 4-fluorophenylboronic acid and 4-methoxyphenylboronic acid 
afforded the corresponding 2-(3-(2'-alkyl-1',2',3',4'-tetrahydro-4'-oxo-
6',8'-diphenylquinazolin-2'-yl)propyl)-6,8-diphenylquinazolin-4(3H)-one  derivatives without 
selectivity due to comparable C‒Br bonds bond strengths. Our results demonstrate the 
importance of the 6,8-dibromo-2-(3-(2´-alkyl-1´,2´,3´,4´-tetrahydro-6´,8´-dibromo-4´-
oxoquinazoline-2yl)propyl)quinazolin-4(3H)-ones as precursors for the synthesis of 
polycarbo-substituted bis-heterocycles with potential photophysical properties. From the 
preliminary electronic absorption and emission spectral property studies, it can be concluded 
that the resultant polyaryl-substituted bis-heterocycles 145a‒l have low fluorescent quantum 
yields and therefore do not represent potential fluorophores. The results of this investigation 
have since been published as a full paper.
105
 
 
Future research extending from this investigation in order to enhance the photophysical and/ 
or biological activities of the resultant bis-heterocycles is expected to include the following: 
 Application of other metal-catalysed cross-coupling reactions such as Sonoghashira, or 
Heck cross-coupling of the 6,8-dibromo-2-(3-(2´-alkyl-1´,2´,3´,4´-tetrahydro-6´,8´-
84 
 
dibromo-4´-oxoquinazoline-2yl)propyl)quinazolin-4(3H)-ones to afford corresponding 
polyalkynyl or polyvinyl bis-heterocycles  
 N(3)-alkylation, acylation, or arylation of the bis-heterocycles to afford the 
corresponding N(3) alkylated, acylated, or arylated bis-heterocycles . 
 Complete aromatisation of quinazolin-4(3H)-one by introducing chlorine atom on the 
C‒4 position and subsequent amination with primary amines or metal-catalyzed cross-
coupling to form bis-heterocyclic compounds consisting of both 4-substituted 
quinazoline and 2,3-dihydroquinazolin-4(1H)-one moieties. 
 Screening the resultant compounds for potential photophysical properties and/ or 
biological properties.  
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CHAPTER 4: EXPERIMENTAL 
 
4.1 General  
 
Solvents and commercially available reagents were used as were supplied or purified by 
conventional methods before use. All methods used were standard to synthetic chemistry and 
all compounds were synthesised in glass flasks, then subjected to the appropriate purification 
technique, such as, chromatography on silica supports, and recrystallization. Thin layer 
chromatography was carried out on silica gel plates, Merck silica gel 60 F254, as stationary 
phase. All air and moisture sensitive reactions were carried out in heat dried glassware under 
inert gas (argon or nitrogen) atmosphere. All melting points were determined on a 
Gallenkamp melting point apparatus and are uncorrected. IR spectra were recorded as 
powders using a Bruker VERTEX 70 FT-IR Spectrometer with a diamond ATR (attenuated 
total reflectance) accessory by using the thin-film method. The UV-vis spectra were recorded 
on a Cecil CE 9500 (9000 Series) UV-Vis spectrometer while emission spectra were taken 
using a Perkin Elmer LS 55 fluorescence spectrometer. The quantum efficiencies of 
fluorescence (Φx) were obtained with the following equation: 
Φx = Φst*(Fx/Fst)*(Ast/Ax)*(nx2/nst2) 
F denotes the area under the fluorescence band (F = aIfl(λ), where Ifl(λ) is the fluorescence 
intensity at each emission wavelength), A denotes the absorbance at the excitation 
wavelength, and n is the refractive index of the solvent.
20
 
1
H NMR spectra were obtained on a 
varian mercury 300 MHz NMR spectrometer using DMSO-d6 as solvents. The chemical shifts 
(δ)  are recorded as parts per million (ppm) and signals are expressed as s (singlet), d 
(doublet), t (triplet), q (quartet), m (multiplet) or br (broad). Coupling constant J values are in 
hertz (Hz). Low- and high-resolution mass spectra were recorded at the University of 
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Stellenbosch Mass Spectrometry Unit using Synapt G2 Quadrupole Time-of-flight mass 
spectrometer. 
 
4.2 Preparation of 2-amino-3, 5-dibromobenzamide 142  
 
A stirred solution of 2-aminobenzamide 17 (5.00 g, 36.75 mmol) in acetic acid was treated 
with N-bromosuccinimide (14.39 g, 80.84 mmol). The mixture was stirred at room 
temperature for 3 hours. The reaction was quenched by addition of cold water and the 
precipitate obtained was filtered and washed with warm ethanol to afford 82 (8.41 g, 78%); 
m.p. 211‒215 °C (Lit. 216–217 ºC);70 1H NMR (DMSO-d6, 300 MHz): δH 6.79 (2H, s, NH2), 
7.46 (1H, s, NH2), 7.73 (1H, d, J 2.4 Hz, ArH), 7.78 (1H, d, J 2.1 Hz, ArH), 8.050 (1H, s, 
NH2) 
 
4.3 Preparation of 6, 8-dibromo-2-(3-(2'-alkyl- 6', 8'-dibromo-1', 2', 3', 4'-tetrahydro-
4'-oxoquinazoline-2'yl)propyl)quinazolin-4(3H)-one derivatives (144a‒d)  
O
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N
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4.3.1 Preparation of 6,8-dibromo-2-(3-(6',8'-dibromo-1',2',3',4'-tetrahydro-2'-methyl-
4'-oxoquinazolin-2'-yl)propyl)quinazolin-4(3H)-one (144a) 
 
A mixture of 2-amino-3,5-dibromobenzamide 142 (1.10 g, 3.74 mmol), 1,3-cyclohexanedione 
143a (0.19 g, 1.70 mmol), and iodine (0.13 g, 0.51 mmol) in refluxing toluene was stirred for 
5 hours. The progress of the reaction was monitored by TLC (ethyl acetate/n-hexane). After 
the completion of the reaction, toluene was evaporated under reduced pressure and the solid 
obtained was purified by recrystallization from ethanol to afford  144a as solid  (0.96 g, 85%); 
m.p. 286‒290 °C; 1H NMR (DMSO-d6, 300 MHz): δH 1.44 (3H, s, CH3), 1.70‒1.91 (4H, m, 
4H, 2 x CH2), 2.41 (2H, d, J  4.8 Hz, CH2), 6.24 (1H, s, NH), 7.65 (1H, s, ArH), 7.69 (1H, s, 
ArH), 8.14 (1H, s, ArH), 8.29 (1H, s, ArH), 8.37 (1H, s, NH), 12.57 (1H, s, NH); 
13
C NMR 
(DMSO-d6, 75 MHz): δC 21.76, 28.27, 34.84, 70.23 (2 x C), 107.59, 108.66, 117.19, 118.47, 
123.48, 123.91 128.13, 129.57, 138.17, 139.86, 143.83, 145.95, 159.36, 160.80, 161.22; ν
max 
(neat)/cm
-1
 3379, 3196, 3056, 1669, 1600, 1464, 1386, 1253, 1075, 897, 808, 760, 697, 619; 
m/z (100, MH
+
) 656; HRMS (ES): MH
+
, found: 664.8046. C20H17Br4N4O2
+ 
requires: 
664.8044. 
 
4.3.2 Preparation of 6,8-dibromo-2-(3-(1',2',3',4'-tetrahydro-6',8'-dibromo-2'-methyl-
4'-oxoquinazoline-2'-yl)2-methylpropyl)quinazoline-4(3H)-one (144b) 
 
2-Amino-3,5-dibromobenzamide 142 (1.10 g; 3.74 mmol) was reacted with 5-methyl-1,3-
cyclohexanedione 143b (0.215 g; 1.70 mmol), and iodine (0.13 g; 0.51 mmol) in refluxing 
toluene for 12 hours. Solvent evaporation and recrystallization from ethanol afforded 144b as 
a solid (0.96 g, 83%); m.p. 312‒314 °C; 1H NMR (DMSO-d6, 300 MHz): δH 1.03 (3H, d, J 
7.8 Hz, CH3), 1.45 (H, s, 3 x CH3), 1.54‒1.62 (1H, q, CH), 2.39‒2.50 (4H, m, 2 x CH2), 6.23 
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(1H, s, NH), 7.29 (1H, s, ArH), 7.59 (1H, s, ArH), 8.12 (1H, s, ArH), 8.25 (1H, s, ArH), 8.34 
(1H, s, NH), 12.52 (1H, s, NH); 
13
C NMR (DMSO-d6, 75 MHz): δC 22.66, 28.04, 28.39, 
43.16, 46.04, 70.19, 107.55, 108.40, 117.19, 118.47, 123.45, 123.78, 128.03, 129.65, 137.62, 
139.90, 143.17, 145.73, 158.37, 160.78, 161.22; ν
max 
(neat)/cm
-1
 3389, 3177, 1673, 1614, 
1597, 1560, 1488, 1445, 1364, 1344, 1225, 1133, 1017, 939, 875, 737, 681, 626; m/z (100, 
MH
+
) 679; HRMS (ES): MH
+
, found: 678.8203. C21H19Br4N4O2
+
 requires: 678.8201. 
 
4.3.3 Preparation of 6,8-dibromo-2-(3-(1',2',3',4'-tetrahydro-6',8'-dibromo-2'-methyl-
4'-oxoquinazoline-2'-yl)2,2-dimethylpropyl)quinazoline-4(3H)-one  (144c) 
 
2-Amino-3, 5-dibromobenzamide 142 (1.10 g, 3.74 mmol) was reacted with 5,5-dimethyl-1,3-
cyclohexanedione 143c (0.24 g, 1.70 mmol), and iodine (0.13 g, 0.51 mmol) in refluxing 
toluene for 24 hours. After the work-up and recrystallization from ethanol, 144c was afforded 
as solid (0.74 g, 63%); m.p. 315‒318 ºC; 1H NMR (DMSO-d6, 300 MHz): δH 1.04 (3H, s, 
CH3), 1.07 (3H, s, CH3), 1.12 (3H, s, CH3),  1.79 (1H, d, J 15.3 Hz, CH2), 2.28 (1H d, J 15.3 
Hz, , CH2), 2.65 (1H, d, J 13.8 Hz, CH2), 3.04 (1H, d, J 13.5 Hz, CH2), 6.68 (1H, s, NH), 7.63 
(1H, s, ArH), 7.71 (1H, s, ArH), 8.18 (1H, s, ArH), 8.34 (1H, s, ArH), 8.45 (1H, s, NH), 12.64 
(1H, s, NH); 
13
C NMR (DMSO-d6, 75 MHz): δC 29.07, 30.07, 32.08, 35.08, 44.73, 46.53, 
71.02, 107.26, 108.57, 116.39, 118.76, 123.09, 123.91, 128.23, 129.53, 138.23, 140.07, 
143.33, 145.49, 158.34, 160.61, 160.91; ν
max 
(neat)/cm
-1
 3397, 3167, 3053, 1685, 1655, 1606, 
1491, 1464, 1440, 1318, 1250, 1214, 1028, 894, 794, 758, 696, 642, 612; m/z (100, MH
+
) 
693; HRMS (ES): MH
+
, found: 692.8359. C22H21Br4N4O2
+ 
requires: 692.8357. 
 
 
89 
 
4.3.4 Preparation of 6,8-dibromo-2-(3-(1',2',3',4'-tetrahydro-6',8'-dibromo-2'-ethyl-4'-
oxoquinazoline-2'-yl)propyl)quinazoline-4(3H)-one (144d) 
 
A mixture of 2-amino-3,5-dibromobenzamide 142 (1.10 g, 3.74 mmol), 2-methyl-1,3-
cyclohexanedione 143d (0.22 g, 1.70 mmol), and iodine (0.13 g, 0.51 mmol) in refluxing 
toluene was stirred at 110º C for 24 hours. After the work-up and recrystallization from 
ethanol, 144d was afforded as a solid (0.69 g, 60%); m.p. 307‒310 ºC; 1H NMR (DMSO-d6, 
300 MHz): δH 0.83 (3H, t, J 6 Hz, CH3), 1.57‒1.92 (6H, m, 3 x CH2), 2.59‒2.60 (2H, m, 
CH2), 6.05 (1H, s, NH), 7.63 (1H, s, ArH), 7.67 (1H, s, ArH), 8.130 (1H, s, ArH), 8.22 (1H, s, 
NH), 8.28 (1H, s, ArH),  12.56 (1H, s, NH); 
13
C NMR (DMSO-d6, 75 MHz): δC 8.31, 21.43, 
33.43, 34.89, 73.11 (2 x C), 106.97, 108.10, 116.54, 118.47, 123.47, 123.94, 128.14, 129.42, 
138.15, 139.87, 144.25, 145.97, 159.41, 160.82, 161.39; ν
max 
(neat)/cm
-1
 3389.38, 3178, 1673, 
1614, 1489, 1445, 1363, 1344, 1259, 1225, 1133, 1017, 939, 870, 780, 737, 681, 626; m/z 
(100, MH
+
) 679; HRMS (ES): MH
+
, found: 678.8203. C21H19Br4N4O2
+ requires: 678.8201. 
 
4.4   Preparation of 2-(3-(2'-alkyl-1',2',3',4'-tetrahydro-4'-oxo-6',8'-diphenylquinazolin-
2'-yl)propyl)-6,8-diphenylquinazolin-4(3H)-one derivatives (145a‒l) 
 
A stirred mixture of 144 (1.0 mmol), arylboronic acid (5.0 equiv.), K2CO3 (4.0 equiv.), 
PdCl2(PPh3)2 (10% of 144), PCy3 (20% of 144) in dioxane-water (3:1, v/v) was placed in a 
two-necked flask with a stirrer bar, rubber septum, and a condenser. The mixture was flushed 
with N2 gas for five minutes and a balloon filled with N2 gas was connected on top of the 
condenser. The mixture was heated under stirring for four hours. The progress of the reaction 
was monitored by tlc (methanol:ethyl acetate). After the completion of the reaction, the 
mixture was cooled to room temperature and then quenched with ice-cold water. The mixture 
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was filtered and the solid obtained was dried and recrystallized from 20% ethyl 
acetate/hexane to afford 145a‒l. 
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145a–l 
The following products were prepared in this fashion: 
 
4.4.1 Preparation of 2-(3-(1',2',3',4'-tetrahydro-2'-methyl-4'-oxo-6',8'-
diphenylquinazolin-2'-yl)propyl)-6,8-diphenylquinazolin-4(3H)-one (145a) 
 
A mixture of  144a (0.50 g, 0.75 mmol), phenylboronic acid (0.50 g, 3.77 mmol), 
PdCl2(PPh3)2 (0.05 g, 0.07 mol), PCy3 (0.04 g; 0.15 mmol) and K2CO3 (0.42 g; 3.01 mmol) in 
dioxane-water (40 mL) afforded 145a as a solid (0.39 g, 80%); mp. 203‒206 ºC; 1H NMR 
(300 MHz, DMSO-d6): δH 1.37 (s, 3H), 1.69–1.84 (m, 4H), 2.55 (s, 2H), 5.62 (s, 1H),      
7.25–7.52 (m, 15H), 7.61 (d, J 7.8 Hz, 2H), 7.68 (d, J 7.5 Hz, 2H), 7.80 (d, J 7.5 Hz, 2H), 
7.95 (s, 1H), 8.02 (s, 1H), 8.18 (s, 1H), 8.33 (s, 1H), 12.33 (s, 1H); 
13
C NMR (75 MHz, 
DMSO-d6): δC 27.0, 33.2 (2 × C), 39.9, 74.9, 120.5, 127.5, 128.0, 130.1, 131.2, 132.0, 132.2, 
132.4, 132.7, 133.0, 133.1, 133.4, 134.1, 134.3, 134.4 (2 × C), 134.5, 134.6, 136.1, 138.3, 
138.8, 142.8, 143.2, 143.8, 144.3, 144.5, 145.1, 148.5, 150.8, 162.1, 167.6, 168.3; νmax (neat) 
cm
-1 
3389, 3178, 1673, 1614, 1560, 1488, 1445, 1364, 1344, 1259, 1225, 1133, 1017, 939, 
875, 737, 681; m/z (100, MH
+
) 653; HRMS (ES): MH
+
, found: 653.2914. C44H37N4O2
+
 
requires: 653.2917. 
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4.4.2 Preparation of 2-(3-(6',8'-bis(4-fluorophenyl)-1',2',3',4'-tetrahydro-2'-methyl-4'-
oxoquinazolin-2'-yl)propyl)-6,8-bis(4-fluorophenyl)quinazolin-4(3H)-one (145b) 
 
A mixture of 144a (0.50 g, 0.75 mmol), 4-fluorophenylboronic acid (0.53 g, 3.77 mmol), 
PdCl2(PPh3)2 (0.05 g, 0.07 mmol), PCy3 (0.04 g; 0.15 mmol) and K2CO3 (0.42 g; 3.01 mmol) 
in dioxane-water (40 mL) afforded 145b as a solid (0.44 g, 81%); mp. 241‒243 ºC; 1H NMR 
(300 MHz, DMSO-d6): δH 1.36 (s, 3H), 1.64–1.80 (m, 4H), 2.50–2.54 (m, 2H), 5.70 (s, 1H), 
7.17–7.35 (m, 7H), 7.40 (d, J 3.0 Hz, 1H), 7.47 (dd, J 6.0 and 6.9 Hz, 2H), 7.62 (dd, J 8.4 and 
4.8 Hz, 2H), 7.74 (dd, J 8.4 and 4.8 Hz, 2H), 7.84–7.89 (m, 4H), 8.02 (s, 1H), 8.16 (s, 1H), 
8.29–8.30 (d, J = 3.0 Hz, 1H), 12.34 (s, 1H); 13C NMR (75 MHz, DMSO-d6): δC 21.9, 28.3 (2 
× C), 34.8, 69.9, 114.9 (d, 
2
JCF 21.0 Hz), 115.4, 116.1 (d, 
2
JCF 21.4 Hz), 116.3 
(d, 
2
JCF 21.1 Hz), 116.4 (d, 
2
JCF 21.3 Hz), 122.4, 123.0, 125.1, 127.1, 128.0, 128.1 (d, 
3
JCF 8.3 
Hz), 129.5 (d, 
3
JCF 7.9 Hz), 131.5 (d, 
3
JCF 8.3 Hz), 133.0 (d, 
3
JCF 7.9 Hz), 133.3, 133.7, 134.5 
(d, 
4
JCF 3.2 Hz), 135.0 (d, 
4
JCF 3.2 Hz), 135.9 (d, 
4
JCF 3.2 Hz), 136.6 (d, 
4
JCF 2.9 Hz), 136.8, 
138.1, 143.6, 145.6, 157.2, 160.5, 161.7 (d, 
1
JCF 241.1 Hz), 162.2 (d, 
1
JCF 242.2 Hz, 2 × C), 
162.7 (d, 
1
JCF 243.6 Hz), 162.5, 163.3; νmax (neat) cm
-1 
3409, 3180, 3043, 1685, 1653, 1623, 
1608, 1508, 1480, 1465, 1225, 1158, 905, 824, 557; m/z (100, MH
+
) 725; HRMS (ES): MH
+
, 
found: 725.2546. C44H33F4N4O2
+
 requires: 725.2540. 
 
4.4.3 Preparation of 2-(3-(1',2',3',4'-tetrahydro-6',8'-bis(4-methoxyphenyl)-2'-methyl-
4'-oxoquinazolin-2'-yl)propyl)-6,8-bis(4-methoxyphenyl)quinazolin-4(3H)-one 
(145c) 
 
A mixture of 144a (0.50 g, 0.75 mmol), 4-methoxyphenylboronic acid (0.57 g, 3.77 mmol), 
PdCl2(PPh3)2 (0.054 g, 0.07 mmol), PCy3 (0.04 g; 0.15 mmol) and K2CO3 
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(0.42 g; 3.01 mmol) in dioxane-water (40 mL) afforded 145c as a solid (0.43 g, 74%); mp. 
181‒184 ºC; 1H NMR (300 MHz, DMSO-d6): δH 1.32 (s, 3H), 1.62–1.78 (m, 4H), 2.46 (s, 
2H), 5.47 (s, 1H), 3.72 (s, 2H), 3.73 (s, 3H), 3.78 (s, 3H), 6.90 (d, J 3.0 Hz, 2H), 6.90–6.96 
(m, 6H), 7.03 (d, J 9.3 Hz, 2H), 7.34 (d, J 7.5 Hz, 2H), 7.48 (d, J 7.8 Hz, 2H), 7.61 (d, J 7.8 
Hz, 2H), 7.71 (d, J 9.0 Hz, 2H), 7.80 (s, 1H), 7.92 (s, 1H), 8.10 (s, 1H), 8.20 (s, 1H), 12.24 (s, 
2H); 
13
C NMR (75 MHz, DMSO-d6): δC 28.2 (2 × C), 34.8, 55.4, 55.5, 55.6, 55.7, 66.9, 69.8, 
113.6, 114.8, 114.9, 115.0, 115.4, 121.7, 122.5, 124.2, 126.7, 127.3, 127.7, 127.8, 128.3 
128.5, 129.0, 130.4, 130.5, 131.2, 131.9, 132.2, 132.7, 133.0, 137.5, 138.8, 143.2, 145.2, 
156.5, 158.7, 159.1, 159.7, 162.7, 163.5; νmax (neat) cm
-1 
3376, 3195, 2933, 1668, 1607, 1513, 
1462, 1379, 1287, 1254, 1177, 1028, 1109, 9345, 824, 792; m/z (100, MH
+
) 773; HRMS 
(ES): MH
+
, found: 773.3356. C48H45N4O6
+
 requires: 773.3339. 
 
4.4.4 Preparation of 2-(3-(1',2',3',4'-tetrahydro-2'-methyl-4'-oxo-6',8'-
diphenylquinazolin-2'-yl)2-methylpropyl)-6,8-diphenylquinazolin-4(3H)-one 
(145d) 
 
A mixture of 144b (0.50 g, 0.74 mmol), phenylboronic acid (0.45 g, 3.69 mmol), 
PdCl2(PPh3)2 (0.05 g, 0.07 mmol), PCy3 (0.04 g, 0.15 mmol) and K2CO3 (0.41 g, 2.95 mmol) 
in dioxane-water (40 mL) afforded 145d as a solid (0.37 g, 75%);  mp. 211‒215 ºC; 1H NMR 
(300 MHz, DMSO-d6): δH 1.00 (d, J 4.5 Hz, 3H), 1.35 (s, 3H), 1.69–1.82 (m, 2H), 2.32–2.55 
(m, 3H), 5.62 (s, 1H), 7.26–7.53 (m, 15H), 7.61 (d, J 7.8 Hz, 2H), 7.68 (d, J 6.0 Hz, 2H), 7.79 
(d, J 6.3, 2H), 7.96 (s, 1H), 8.01 (s, 1H), 8.16 (s, 1H), 8.32 (s, 1H), 12.26 (s, 1H); 
13
C NMR 
(75 MHz, DMSO-d6): δC 21.8, 28.4 (2 × C), 43.2, 46.1, 70.1, 115.7, 122.5, 123.0, 125.1, 
126.2, 127.0, 127.4 (2 × C), 127.6, 128.0, 128.1, 128.3, 128.4, 129.3, 129.4 (2 × C), 129.6, 
131.0, 133.2, 133.8, 137.8, 138.2, 138.9, 139.4, 139.5, 140.1, 143.4, 145.8, 156.2, 162.6, 
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163.5 ; νmax (neat) cm
-1 
3397, 3167, 1685, 1655, 1606, 1491, 1464, 1388, 1318, 1250, 1195, 
1028, 894, 758, 696; m/z (100, MH
+
) 668; HRMS (ES): MH
+
, found: 667.3065. C45H39N4O2
+
 
requires: 667.3073. 
 
4.4.5  Preparation of 2-(3-(6',8'-bis(4-fluorophenyl)-1',2',3',4'-tetrahydro-2'-methyl-4'-
oxoquinazolin-2'-yl)-2-methylpropyl)-6,8-bis(4-fluorophenyl)quinazolin-4(3H)-
one (145e) 
 
A mixture of 144b (0.50 g, 0.74 mmol), 4-fluorophenylboronic acid (0.52 g, 3.69 mmol), 
PdCl2(PPh3)2 (0.05 g, 0.07  mmol), PCy3 (0.04 g, 0.15 mmol) and K2CO3 (0.41 g, 2.95 mmol) 
in dioxane-water (40 mL) afforded 145e as a solid (0.38 g, 70%); mp. 265‒268 ºC; 1H NMR 
(300 MHz, DMSO-d6): δH 0.99 (d, J 6.3 Hz, 3H), 1.33 (s, 3H), 1.63–1.84 (m, 2H), 2.34–2.43 
(m, 3H), 5.76 (s, 1H), 7.11–7.24 (m, 5H), 7.29–7.38 (m, 3H), 7.44 (dd, J 6.3 and 8.4 Hz, 2H), 
7.62 (dd, J 6.3 and 8.4 Hz, 2H), 7.73 (dd, J 6.0 and 9.3 Hz, 3H), 7.84 (dd, J 6.0 and 8.5 Hz, 
2H), 7.89 (d, J 3.0 Hz, 1H) 8.15 (s, 1H), 8.23 (s, 1H), (s, 1H), 12.27 (s, 1H); 
13
C NMR (75 
MHz, DMSO-d6): δC 22.1, 28.4 (2 × C), 46.6, 70.1, 114.8 (d, 
2
JCF 21.1 Hz), 115.8, 116.1 (d, 
2
JCF 21.4 Hz), 116.2 (d, 
2
JCF 21.0 Hz), 116.3 (d, 
2
JCF 21.1 Hz), 122.3, 123.3, 125.1, 127.4, 
128.1 (2 × C), 128.2 (d, 
3
JCF 7.7 Hz), 129.2 (d, 
3
JCF 8.3 Hz), 131.5 (d, 
3
JCF 7.9 Hz), 132.1, 
132.9 (d, 
3
JCF 7.9 Hz), 133.1, 134.4 (d, 
4
JCF 2.9 Hz), 134.8, 135.8 (d, 
4
JCF 2.9 Hz), 136.6 (d, 
4
JCF 3.1 Hz), 136.7 (d, 
4
JCF 3.1 Hz), 137.1, 143.6 (2 × C), 147.2, 161.8 (d, 
1
JCF 239.6 Hz), 
161.9 (d, 
1
JCF 242.2 Hz), 162.1 (d, 
1
JCF 241.0 Hz), 162.4 (d, 
1
JCF 242.8 Hz), 163.4 (2 × C); 
νmax (neat) cm
-1 
3409, 3178, 3042, 1692, 1655, 1608, 1507, 1467, 1227, 1158, 1096, 1012, 
907, 821, 558; m/z (100, MH
+
) 739; HRMS (ES): MH
+
, found: 739.2703. C45H35F4N4O2
+
 
requires: 739.2696. 
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4.4.6 Preparation of 2-(3-(1',2',3',4'-tetrahydro-6',8'-bis(4-methoxyphenyl)-2'-methyl-
4'-oxoquinazolin-2-yl)-2'-methylpropyl)-6,8-bis(4-methoxyphenyl)quinazolin-
4(3H)-one (145f) 
 
A mixture of 144b (0.50 g, 0.74 mmol), 4-methoxyphenylboronic acid (0.56 g, 3.69 mmol), 
PdCl2(PPh3)2 (0.05 g, 0.07 mmol), PCy3 (0.04 g, 0.15 mmol) and K2CO3 (0.41 g, 2.95 mmol) 
in dioxane-water (40 mL) afforded 145f as a solid (0.42 g, 73%); mp. 194‒196 ºC; 1H NMR 
(300 MHz, DMSO-d6): δH 0.97 (d, J 6.3 Hz, 3H), 1.35 (s, 3H), 1.67–1.81 (m, 2H), 2.35–2.41 
(m, 3H), 3.71 (s, 3H), 3.75 (s, 3H), 3.77 (s, 3H), 3.81 (s, 3H), 5.50 (s, 1H), 6.94 (t, J 7.5 Hz, 3 
× 2H), 7.05 (d, J 9.0 Hz, 2H), 7.32–7.34 (m, 3H), 7.51 (d, J 7.5, 2H), 7.63 (d, J 7.5 Hz, 2H), 
7.73 (d, J 7.8 Hz, 2H), 7.85 (s, 1H), 7.94 (s, 1H), 8.13 (s, 1H), 8.22 (s, 1H), 12.18 (s, 1H); 
13
C 
NMR (75 MHz, DMSO-d6): δC 21.8, 28.2 (2 × C), 43.1, 46.2, 55.4, 55.5, 55.6, 55.7, 70.0, 
113.6, 114.8 (2 × C), 115.0, 115.7, 121.7, 122.4, 124.1, 127.3, 128.1, 128.5, 129.1, 130.3, 
130.5, 131.1, 131.9, 132.2 (2 × C), 132,7, 133.0, 137.5, 138.9, 142.9, 145.2, 155.6, 158.7, 
159.0 (2 × C), 159.7, 162.6, 163.7; νmax (neat) cm
-1 
33946, 3158.7, 2834, 1677, 1607, 1512, 
1463, 1285, 1244, 1178, 1030, 828; m/z (100, MH
+
) 787; HRMS (ES): MH
+
, found: 
787.3502. C49H47N4O6
+
 requires: 787.3496. 
 
4.4.7 Preparation of 2-(3-(1',2',3',4'-tetrahydro-2'-methyl-4'-oxo-6',8'-
diphenylquinazolin-2'-yl)2,2-dimethylpropyl)-6,8-diphenylquinazolin-4(3H)-one 
(145g) 
 
A mixture of 144c (0.50 g, 0.72 mmol), phenylboronic acid (0.44 g, 3.62 mmol), 
PdCl2(PPh3)2 (0.05 g, 0.07  mmol), PCy3 (0.04 g, 0.15 mmol) and K2CO3 (0.40 g, 2.89 mmol) 
in dioxane-water (40 mL) afforded 145g as a solid (0.37 g, 76%); mp. 289‒292 ºC; 1H NMR 
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(300 MHz, DMSO-d6): δH 0.89 (s, 3H), 1.02 (s, 3H), 1.11 (s, 3H) 1.55 (d, J 15.0 Hz, 1H), 
2.10 (d, J 13.8 Hz, 1H), 2.64 (d, J 15.3 Hz, 1H), 2.97 (d, J 13.5 Hz, 1H), 5.26 (s, 1H), 7.08 (t, 
J 7.8 Hz, 2H) 7.22–7.45 (m, 13H), 7.52 (t, J 7.5 Hz, 2H), 7.61 (d, J 7.8 Hz, 2H), 7.84 (d, J 7.8 
Hz, 2H), 7.93 (d, J 6.0 Hz, 2H), 7.99 (s, 1H), 8.36 (s, 1H) 12.27 (s, 1H); 
13
C NMR (75 MHz, 
DMSO-d6): δC 29.7, 29.9, 31.0, 35.0, 45.2, 46.6, 56.6, 70.6, 115.1, 122.4, 123.1, 125.1, 126.2, 
127.0, 127.2, 127.4, 127.7, 127.8, 127.9, 128.1, 128.4, 129.0, 129.1, 129.4, 129.7, 130.6, 
133.2, 134.1, 137.8, 139.3, 139.4, 139.8, 140.1, 142.9, 145.4, 156.1, 162.4, 162.8; νmax (neat) 
cm
-1 
3410, 3194, 3055, 1688, 1627, 1601, 1518, 1495, 1465, 1385, 1260, 1213, 1029, 894, 
788, 762, 698; m/z (100, MH
+
) 682; HRMS (ES): MH
+
, found: 681.3232. C46H41N4O2
+
 
requires: 681.3230. 
 
4.4.8 Preparation of 2-(3-(6',8'-bis(4-fluorophenyl)-1',2',3',4'-tetrahydro-2'-methyl-4'-
oxoquinazolin-2'-yl)-2,2-dimethylpropyl)-6,8-bis(4-fluorophenyl)quinazolin-4(3H)-
one (145h) 
 
A mixture of 144c (0.50 g, 0.72 mmol), 4-fluorophenylboronic acid (0.51 g, 3.62 mmol), 
PdCl2(PPh3)2 (0.05 g, 0.07  mmol), PCy3 (0.04 g, 0.15 mmol) and K2CO3 (0.40 g, 2.89 mmol) 
in dioxane-water (40 mL) afforded 145h as a solid (0.42 g, 77%); mp. 303‒305 ºC; 1H NMR 
(300 MHz, DMSO-d6): δH 1.01 (s, 3H), 1.05 (s, 3H), 1.07 (s, 3H) 1.59 (d, J 15.3 Hz, 1H), 
2.06 (d, J 15.3 Hz, 1H), 2.67 (d, J 13.8 Hz, 1H), 2.85 (d, J 15.3 Hz, 1H), 5.39 (s, 1H), 7.05 (t, 
J 9.0 Hz, 2H), 7.17 (t, J 9.0 Hz, 2H), 7.20 (t, J 9.0 Hz, 2H), 7.30–7.39 (m, 5H), 7.50 (t, J 6.3 
Hz, 2H), 7.62 (t, J 6.3 Hz, 2H), 7.85–7.88 (m, 3H), 7.93 (s, 1H), 8.02 (br s, 1H), 8.32 (s, 1H), 
12.27 (s, 1H); 
13
C NMR (75 MHz, DMSO-d6): δC 29.7, 30.0, 30.9, 35.0, 45.4, 47.0, 70.5, 
115.0, 115.2 (d, 
2
JCF 20.5 Hz), 116.0 (d, 
2
JCF 21.1 Hz), 116.1 (d, 
2
JCF 21.4 Hz), 116.4 (d, 
2
JCF 
21.4 Hz), 122.3, 123.1, 125.0, 127.1, 128.0, 128.1 (d, 
3
JCF 8.0 Hz), 129.5 (d, 
3
JCF 8.0 Hz), 
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131.2 (d, 
3
JCF 8.3 Hz), 132.7 (d, 
3
JCF 8.0 Hz), 133.2, 134.0, 134.1 (d, 
4
JCF 3.2 Hz), 135.4 (d, 
4
JCF 3.2 Hz), 135.9 (d, 
4
JCF 2.9 Hz), 136.5 (d, 
4
JCF 2.9 Hz), 136.9, 138.5, 143.0, 145.3, 156.4, 
161.8 (d, 
1
JCF 241.7 Hz), 162.0 (d, 
1
JCF 243.0 Hz), 162.1 (d, 
1
JCF 242.4 Hz), 162.6 (d, 
1
JCF 
243.5 Hz), 162.3, 162.6; νmax (neat) cm
-1 
3387, 3181, 3048, 1688, 1653, 1608, 1507, 1466, 
1381, 1222, 1158, 1015, 825, 804, 791, 636, 565, 517; m/z (100, MH
+
) 753; HRMS (ES): 
MH
+
, found: 753.2855. C46H37F4N4O2
+
 requires 753.2853. 
 
4.4.9 Preparation of 2-(3-(1',2',3',4'-tetrahydro-6',8'-bis(4-methoxyphenyl)-2'-methyl-
4'-oxoquinazolin-2'-yl)-2,2-dimethylpropyl)-6,8-bis(4-methoxyphenyl)quinazolin-
4(3H)-one (145i) 
 
A mixture of 144c (0.50 g, 0.72 mmol), 4-methoxyphenylboronic acid (0.55 g, 3.62 mmol), 
PdCl2(PPh3)2 (0.05 g, 0.07 mmol), PCy3 (0.04 g, 0.15 mmol) and K2CO3 (0.40 g, 2.89 mmol) 
in dioxane-water (40 mL) afforded 145i as a solid (0.47 g, 81%); mp. 228‒230 ºC; 1H NMR 
(300 MHz, DMSO-d6): δH 0.93 (s, 3H), 1.03 (s, 3H), 1.08 (s, 3H) 1.57 (d, J 15.3 Hz, 1H), 
2.06 (d, J 13.8 Hz, 1H), 2.67 (d, J 13.8 Hz, 1H), 2.94 (d, J 13.8 Hz, 1H), 3.56 (s, 3H), 3.69 (s, 
3H), 3.77 (s, 3H), 3.82 (s, 3H), 5.27 (s, 1H), 6.79 (d, J 9.0 Hz, 2H) 6.88 (d, J 9.3 Hz, 2H), 
6.96 (d, J 9.3 Hz, 2H), 7.07 (d, J 9.3 Hz, 2H), 7.31 (d, J 7.8 Hz, 2 x 2H), 7.52 (d, J 9.0 Hz, 
2H), 7.75 (d, J 9.0 Hz, 2 × 2H), 7.85 (d, J 3.3 Hz, 2H), 7.95 (s, 1H), 12.22 (s, 1H); 
13
C NMR 
(75 MHz, DMSO-d6): δC 29.8, 30.0, 30.7, 35.1, 45.2, 46.7, 55.4, 55.5, 55.6, 55.7, 70.5, 113.9, 
114.5, 114.8, 115.0, 121.8, 122.2, 124.1, 126.7, 127.3, 127.7, 127.9, 128.3, 128.5, 128.9, 
129.4, 130.1, 130.3, 131.6, 131.8, 132.7, 133.5, 137.5, 139.4, 142.6, 145.0, 155.6, 158.7, 
159.0, 159.7, 162.5, 163.0; νmax (neat) cm
-1 
3177, 3037, 2834, 1677, 1607, 1511, 1463, 1386, 
1244, 1178, 1034, 899, 827; m/z (100, MH
+
) 801; HRMS (ES): MH
+
, found: 801.3665. 
C50H49N4O6
+
 requires: 801.3652. 
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4.4.10 Preparation of 2-(3-(2'-ethyl-1',2',3',4'-tetrahydro-4'-oxo-6',8'-diphenylquinazolin-
2'-yl)propyl)-6,8-diphenylquinazolin-4(3H)-one (145j) 
 
A mixture of 144d (0.500 g, 0.738 mmol), phenylboronic acid (0.45 g, 3.69 mmol), 
PdCl2(PPh3)2 (0.05 g, 0.07 mmol), PCy3 (0.041 g, 0.15 mmol) and K2CO3 (0.41 g, 2.95 
mmol) in dioxane-water (40 mL) afforded 145j as a solid (0.31 g, 63%); mp. 223‒226 ºC; 1H 
NMR (300 MHz, DMSO-d6): δH 0.84 (t, J 7.5 Hz, 3H), 1.57–1.81 (m, 6H), 2.50–2.54 (m, 
2H), 5.40 (s, 1H), 7.27–7.53 (m, 15H), 7.60 (d, J 7.8 Hz, 2H), 7.68 (d, J 7.8 Hz, 2H), 7.81 (d, 
J 7.5 Hz, 2H), 7.94 (d, J 3.0 Hz, 1H), 8.03 (m, 2H) 8.33 (s, 1H), 12.33 (s, 1H); 
13
C NMR (75 
MHz, DMSO-d6): δC 7.9, 21.1, 30.6, 33.1, 34.5, 72.1, 114.2, 121.9, 122.4, 124.5, 125.6, 
126.4, 126.8, 126.9, 127.1, 127.5 (2 × C), 127.8, 128.0, 128.7, 128.8, 129.0, 129.1, 130.5, 
132.7, 133.2, 137.3, 137.7, 138.3, 138.7, 138.9, 139.6, 143.3, 145.2, 157.1, 162.5, 163.3; νmax 
(neat) cm
-
1
 
3384, 3177, 1665, 1600, 1486, 1462, 1438, 1248, 896, 808, 758, 695; m/z (100, 
MH
+
) 668; HRMS (ES): MH
+
, found: 667.3094. C45H39N4O2
+
 requires: 667.3073. 
 
 
4.4.11  Preparation of 2-(3-(2'-ethyl-6',8'-bis(4-fluorophenyl)-1',2',3',4'-tetrahydro-4'-
oxoquinazolin-2'-yl)propyl)-6,8-bis(4-fluorophenyl)quinazolin-4(3H)-one (145k) 
 
A mixture of 144d (0.50 g, 0.74 mmol), 4-fluorophenylboronic acid (0.52 g, 3.69 mmol), 
PdCl2(PPh3)2 (0.05 g, 0.07 mmol), PCy3 (0.04 g, 0.15 mmol) and K2CO3 (0.41 g, 2.95 mmol) 
in dioxane-water (40 mL) afforded 145k as a solid (0.34 g, 63%); mp. 252‒254 ºC; 1H NMR 
(300 MHz, DMSO-d6): δH 0.81 (t, J 7.5 Hz, 3H), 1.52–1.77 (m, 6H), 2.48–2.52 (m, 2H), 5.47 
(s, 1H), 7.13–7.33 (m, 9H), 7.44 (dd, J 6.0 and 6.9 Hz, 2H), 7.59 (dd, J 6.3 and 8.4 Hz, 2H), 
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7.71 (dd, J 6.3 and 8.4 Hz, 2H), 7.81–7.86 (m, 3H), 8.00 (s, 2H), 8.27 (s, 1H), 12.31 (s, 1H); 
13
C NMR (75 MHz, DMSO-d6): δC 8.4, 21.5, 33.7 (2 × C), 34.8, 72.7, 114.5, 114.9 (d, 
2
JCF 
21.1 Hz), 116.1 (d, 
2
JCF 21.1 Hz), 116.4 (d, 
2
JCF 21.4 Hz), 116.5, 122.5, 123.0, 125.0, 126.5, 
127.4, 128.0 (d, 
3
JCF 7.9 Hz), 129.5 (d, 
3
JCF 8.3 Hz), 131.5 (d, 
3
JCF 8.3 Hz), 133.0 (d, 
3
JCF 8.0 
Hz), 133.3, 133.7, 134.5 (d, 
4
JCF 3.1 Hz), 134.9 (d, 
4
JCF 3.2 Hz), 135.9 (d, 
4
JCF 3.1 Hz), 136.6 
(d, 
4
JCF 3.2 Hz), 136.8, 138.1, 144.1, 145.6, 157.2, 161.7 (d, 
1
JCF 241.9 Hz), 162.1 (d, 
1
JCF 
242.5 Hz, 2 × C), 162.5, 163.3, 162.6 (d, 
1
JCF 243.6 Hz); νmax (neat) cm
-1 
3430, 3186, 1690, 
1656, 1652, 1608, 1509, 1482, 1464, 1227, 1158, 1098, 1014, 900, 825, 565; m/z (100, MH
+
) 
740; HRMS (ES): MH
+
, found: 739.2709. C45H35F4N4O2
+
 requires: 739.2696. 
 
4.4.12  Preparation of 2-(3-(2'-ethyl-'1',2',3',4'-tetrahydro-6',8'-bis(4-methoxyphenyl)-
4'-oxoquinazolin-2'-yl)propyl)-6,8-bis(4-methoxyphenyl)quinazolin-4(3H)-one 
(145l) 
 
A mixture of 144d (0.50 g, 0.74 mmol), 4-methoxyphenylboronic acid (0.56 g, 3.69 mmol), 
PdCl2(PPh3)2 (0.05 g, 0.07 mmol), PCy3 (0.04 g, 0.15 mmol) and K2CO3 (0.41 g, 2.95 mmol) 
in dioxane-water (40 mL) afforded 145l as a solid (0.35 g, 60%); mp. 192‒195 ºC; 1H NMR 
(300 MHz, DMSO-d6): δH 0.82 (t, J 7.8 Hz, 3H), 1.54–1.80 (m, 6H), 2.50–2.54 (m, 2H), 3.75 
(s, 6H), 3.77 (s, 3H), 3.81 (s, 3H), 5.26 (s, 1H), 6.92–6.99 (m, 5H,), 7. 06 (d, J 9.3 Hz, 2H), 
7.31 (d, J 3.3 Hz, 2H), 7.35 (d, J 9.3 Hz, 2H), 7.50 (d, J 9.3 Hz, 2H), 7.63 (d, J 9.0 Hz, 2H), 
7.74 (d, J 9.0 Hz, 2H), 7.83 (s, 1H), 7.97 (d, J 9.3 Hz, 2H), 8.23 (s, 1H), 12.25 (s, 1H); 
13
C 
NMR (75 MHz, DMSO-d6): δC 8.5, 21.7, 33.5, 34.9, 55.5, 55.6, 55.7, 55.8, 66.9, 72.6, 113.6, 
114.6, 114.8, 114.9, 115.0, 121.7, 122.5, 124.1, 126.7, 127.2, 127.7, 128.3, 128.4, 128.5, 
129.4, 130.4, 130.5, 131.2, 131.9, 132.2, 132.8, 133.0, 137.5, 138.8, 143.6, 145.2, 156.5, 
158.6, 159.1, 159.1, 162.7, 163.6; νmax (neat) cm
-1 
3387, 3175, 1668, 1607, 1513, 1484, 1464, 
99 
 
1286, 1246, 1180, 1028, 829; m/z (100, MH
+
) 787; HRMS (ES): MH
+
, found: 787.3500. 
C49H47N4O6
+
 requires: 787.3496. 
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APPENDIX 
Mass spectra of 144a, 145a, 145f and 145h 
 
 
 
Figure 24: Mass spectrum of 6,8-dibromo-2-(3-(6,8-dibromo-1,2,3,4-tetrahydro-2-methyl-4-
oxoquinazolin-2-yl)propyl)quinazolin-4(3H)-one (144a) 
 
 
 
Figure 25: Mass spectrum of 2-(3-(1,2,3,4-tetrahydro-2-methyl-4-oxo-6,8-
diphenylquinazolin-2-yl)propyl)-6,8-diphenylquinazolin-4(3H)-one (145a) 
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Figure 26: Mass spectrum of 2-(3-(1,2,3,4-tetrahydro-6,8-bis(4-methoxyphenyl)-2-methyl-4-
oxoquinazolin-2-yl)-2-methylpropyl)-6,8-bis(4-methoxyphenyl)quinazolin-4(3H)-
one (145f) 
 
 
 
Figure 27: Mass spectrum of 2-(3-(6,8-bis(4-fluorophenyl)-1,2,3,4-tetrahydro-2-methyl-4-
oxoquinazolin-2-yl)-2,2-dimethylpropyl)-6,8-bis(4-fluorophenyl)quinazolin-
4(3H)-one (145h) 
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ABSTRACT 
 
3,5-Dibromo-2-aminobenzamide was reacted with 1,3-cyclohexanedione derivatives in the 
presence of iodine as catalyst in toluene under reflux to afford novel 6,8-dibromo-2-[3-(2´-
alkyl-1´,2´,3´,4´-tetrahydro-6´,8´-dibromo-4´-oxoquinazoline-2yl)propyl]quinazolin-
4(3H)-ones in high yields. Suzuki-Miyaura cross-coupling of the latter with arylboronic acids 
in the presence of Pd(PPh3)2Cl2–Xphos catalyst complex and K2CO3 as a base in dioxane-
water mixture (3:1, v/v) afforded the corresponding polyaryl-substituted bis-heterocycles in a 
single step operation. The resultant compounds were characterized using a combination of 
NMR (
1
H and 
13
C) and IR spectroscopic techniques, as well as mass spectrometry. The 
electronic absorption and emission properties of these polyaryl-substituted bis-heterocycles 
comprising 2,3-dihydroquinazolin-4(1H)-one and quinazolin-4(3H)-one moieties linked by a 
flexible carbon chain were measured in dimethylsulfoxide (DMSO) and acetic acid by means 
of UV-Vis and fluorescence spectroscopic techniques. The absorption spectra of the resultant 
polyaryl-substituted bis-heterocycles showed blue-shift in acetic acid and red-shift in DMSO, 
while their emission spectra are blue-shifted in DMSO and red-shifted in acetic acid. The 
4-methoxy groups on aryl-substituents caused red shift on π‒π* transition of the aryl-
substituents. Moreover, it was also observed that as the propyl linkage becomes more 
substituted, the absorption and emission intensities decrease. 
 
Keywords: 2,3-dihydroquinazolin-4(1H)-ones, Quinazolin-4(3H)-ones, 6,8-dibromo-2-[3-(2᾿-
alkyl-1´,2´,3´,4´-tetrahydro-6´,8´-dibromo-4´-oxoquinazoline-
2yl)propyl]quinazolin-4(3H)-ones, Suzuki-Miyaura cross coupling, polyaryl-
substituted bis-heterocycles, photophysical properties 
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